Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814073-151828488	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 224.9;intestine: 241.7;liver: 946.7"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 687.7;Proximal enterocytes: 460.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002911	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	8.2	224.9	0.0	0.4	0.0	0.0	5.0	0.0	0.1	0.1	0.2	0.3	220.9	0.2	0.0	2.7	0.6	27.4	0.7	0.0	0.0	0.2	946.7	9.1	0.3	0.0	0.1	0.1	36.7	0.0	0.0	1.5	0.0	0.1	0.2	0.0	1.3	0.0	0.0	13.8	241.7	0.0	0.0	0.2	52.3	0.8	0.1	0.4	0.3	0.0	2.5	0.7	0.4	0.0	0.0	9.5	0.0	0.0	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.6	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	1.0	0.4	0.1	0.3	1.7	0.0	1.7	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.0	0.9	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.5	0.0	14.3	0.0	0.7	0.3	0.0	4.4	0.0	0.0	0.0	0.0	1.1	71.4	8.7	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	1.8	0.1	0.7	0.0	2.7	0.0	51.9	0.0	39.3	53.5	0.2	0.0	0.0	5.0	687.7	0.2	0.0	0.0	9.6	0.0	14.8	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	10.0	0.0	0.1	0.2	460.5	0.0	2.9	0.0	0.0	0.0	3.4	0.0	0.1	1.4	3.4	0.3	0.7	0.3	18.4	0.2
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"intestine: 47.8;liver: 62.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"Hep G2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	47.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	62.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	5.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.6	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	60.3	0.0	0.0	3.2	2.5	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.8	0.0	23.9	0.0	0.0	0.0	30.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 276.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.5	2.5	7.1	0.6	5.2	0.6	10.7	4.7	5.0	2.8	3.0	3.7	0.8	1.2	7.1	1.0	1.7	2.3	3.3	5.5	7.9	25.4	276.6	2.1	1.9	6.3	6.8	0.8	0.6	1.0	0.5	1.4	6.8	0.6	1.2	0.5	0.9	0.9	13.9	2.3	1.9	1.0	6.7	4.6	3.4	0.9	8.2	0.7	4.2	1.7	0.7	1.1	2.2	8.2	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	7.1	5.2	4.7	5.0	5.5	7.9	6.3	6.8	6.8	6.7	8.2	8.2	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 961.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	79.7	961.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200317-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 122.5"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.0;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 38.5;Proximal enterocytes: 30.5;Proximal tubular cells: 16.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;Karpas-707: 7.7;NTERA-2: 3.5;SCLC-21H: 3.2;TIME: 4.0;WM-115: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057900			Uncertain	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	2.8	0.1	0.9	0.6	2.4	0.1	1.8	0.7	1.9	0.1	0.1	1.2	9.7	0.1	14.5	0.1	0.1	3.6	0.4	0.7	1.4	8.9	122.5	0.2	0.5	1.5	1.4	0.1	0.1	0.0	0.4	0.8	1.5	0.0	0.6	0.1	0.2	0.1	0.3	0.2	14.9	0.1	0.9	0.0	0.3	3.0	1.8	0.2	0.4	0.4	0.1	1.2	0.1	4.1	0.0	2.2	0.0	1.9	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	1.2	0.0	0.7	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.0	1.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	15.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	2.4	0.7	1.9	0.7	1.4	1.5	1.4	1.5	0.9	1.8	4.1	10.0	0.0	0.0	6.8	0.3	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.1	11.5	0.4	3.7	0.0	0.1	0.1	0.5	0.0	0.0	1.3	0.3	0.1	1.2	1.8	2.7	1.3	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.1	83.0	0.1	0.0	1.7	0.4	0.0	1.6	0.5	1.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	33.7	38.5	0.9	0.1	0.0	0.0	0.0	30.5	16.9	0.3	0.0	6.6	0.4	2.4	1.7	6.4	0.1	0.0	0.1	0.2	0.1	0.6	0.0
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 623.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	185.7	14.3	12.3	13.5	16.5	5.8	116.2	16.0	11.5	12.9	6.9	23.2	25.3	6.6	6.6	103.9	11.5	65.7	135.5	10.9	18.7	45.4	623.2	28.9	4.7	22.1	18.4	15.5	23.3	0.8	9.7	1.7	23.2	17.3	12.2	11.5	73.7	12.5	120.4	35.3	23.4	8.7	19.6	4.1	142.9	13.0	22.2	4.6	46.7	27.3	7.8	71.1	31.3	20.3	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.3	16.5	16.0	11.5	10.9	18.7	22.1	18.4	23.2	19.6	22.2	20.3	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 10947.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.7	0.2	0.1	0.0	0.1	0.0	6.4	0.3	0.4	0.2	0.3	0.3	2.3	0.1	0.4	0.3	0.4	160.4	0.5	0.1	0.1	11.0	10947.9	0.3	0.0	0.1	0.1	0.2	125.3	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.3	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425545	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5;Hepatocytes: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	29.6	53.1	49.7	22.8	58.0	36.9	27.5	56.6	48.0	34.4	78.5	29.1	47.5	33.6	51.5	44.2	31.7	29.2	32.1	50.2	56.7	64.8	75.4	27.1	40.2	62.1	58.4	40.1	29.2	70.6	24.2	41.0	62.6	28.0	25.0	57.6	25.6	37.4	159.4	24.9	36.0	33.9	65.3	26.9	24.6	83.7	57.2	20.6	33.8	56.5	43.5	25.8	29.4	75.7	55.5	75.2	32.4	59.2	98.2	54.7	28.4	56.8	71.2	77.0	60.1	66.4	49.4	142.0	65.3	79.1	45.2	50.3	49.9	45.1	72.9	31.7	51.2	40.9	29.2	73.4	85.7	33.2	45.6	64.1	64.3	61.7	73.1	53.6	45.6	41.0	45.7	18.8	56.9	33.7	50.7	35.8	15.3	28.2	51.1	57.0	64.8	53.6	47.9	57.0	32.2	24.6	135.6	47.3	45.5	30.3	142.3	35.0	59.4	72.3	39.4	36.9	39.7	40.7	38.5	75.8	52.7	23.4	33.7	37.1	10.0	14.4	7.9	12.5	11.2	21.7	9.9	8.3	9.9	17.9	10.1	10.9	12.5	14.2	17.9	13.2	11.4	5.5	49.7	58.0	56.6	48.0	50.2	56.7	62.1	58.4	62.6	65.3	57.2	75.7	25.7	9.6	9.0	23.8	34.0	25.7	18.1	11.0	10.8	17.7	58.9	23.0	19.9	28.6	11.7	99.3	39.6	27.5	17.4	53.6	25.4	20.8	154.5	16.4	26.4	23.5	24.7	29.0	20.5	43.0	6.8	31.9	8.6	32.4	8.8	31.8	38.9	166.4	17.0	32.0	23.7	23.6	12.2	69.1	33.2	118.7	41.0	25.5	30.2	23.4	25.5	50.1	10.3	27.6	31.5	35.6	25.3	34.3	12.0	36.0	53.4	54.3	9.2	43.3	13.1	29.4	24.1	30.5	11.7	12.0	20.9	24.4	17.1	34.1	22.9	29.7
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3629.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	47.7	0.2	0.0	0.0	1.3	3629.2	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19248.5"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	3.2	1.4	1.2	3.6	1.2	0.0	2.1	1.1	1.4	0.8	0.8	7.4	1709.3	3.5	0.4	1.1	6.1	1.7	67.2	1.0	1.1	3.7	19248.5	2.7	3.2	1.1	1.1	23.1	2.5	0.0	4.2	1.6	1.1	1.1	0.2	0.1	0.7	1.0	0.8	1.0	4053.7	2.1	1.1	9.0	14.6	384.5	1.2	0.9	3.7	0.2	0.1	0.5	1.5	1.2	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.2	1.2	1.1	1.4	1.0	1.1	1.1	1.1	1.1	1.1	1.2	1.2	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	216	"liver: 582.1"	"Cell type enriched"	"Detected in some"	88	"Hepatocytes: 1249.5"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"Hep G2: 35.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	114000000	21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	582.1	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	35.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	1249.5	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16232.1"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	59.2	1998.1	90.3	28.1	133.0	52.2	87.1	83.3	338.1	29.0	73.6	29.1	13.1	11.0	42.0	5.9	21.2	31.0	10.9	75.3	109.8	14.6	16232.1	289.9	140.1	133.2	152.8	56.4	21.4	16.3	23.6	41.7	121.9	14.4	16.7	15.1	35.5	2.2	22.2	73.1	49.1	4.0	92.7	254.9	22.7	18.7	139.2	37.4	36.3	6.1	33.9	23.5	11.3	169.4	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	90.3	133.0	83.3	338.1	75.3	109.8	133.2	152.8	121.9	92.7	139.2	169.4	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOC4-APOC2		ENSG00000224916	"APOC4-APOC2 readthrough (NMD candidate)"		19	44942238-44949565	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	1258	"liver: 2221.0"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 147.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 9.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"THP-1: 4.2"									HPA055877	Supported					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA055877: AB_2682953"	"unprognostic (1.45e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.68e-2)"	0.1	0.4	0.7	0.0	0.6	0.0	0.2	0.7	0.8	0.2	0.6	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.6	0.6	0.8	2221.0	1.7	0.0	0.7	0.7	0.0	0.3	0.0	0.8	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	1.2	0.1	0.4	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.7	0.8	0.6	0.6	0.7	0.7	0.8	0.7	0.9	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	147.1	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 110.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA041420: AB_2677469, HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	11.9	16.6	20.4	11.4	20.4	16.7	11.7	21.6	27.8	13.9	19.8	12.4	10.0	14.7	6.1	18.7	11.7	6.9	17.9	21.2	21.7	16.9	110.5	11.9	15.8	22.9	21.2	12.0	11.2	11.9	17.8	8.8	22.7	15.6	8.9	7.7	13.3	8.0	21.3	12.7	12.3	9.1	19.5	17.8	12.3	24.0	20.3	23.2	19.4	18.2	12.4	14.4	12.6	20.8	64.1	42.8	30.7	38.0	14.5	24.7	39.7	40.3	23.5	64.5	47.7	59.8	56.0	96.3	63.8	34.1	23.8	31.8	73.7	47.8	35.5	20.4	104.0	48.5	39.0	49.0	32.0	87.1	54.3	31.2	44.9	44.0	30.7	14.5	41.6	56.3	86.4	36.0	36.0	78.0	93.2	70.5	71.5	71.9	86.8	76.3	27.7	68.9	31.9	42.6	70.5	30.6	32.4	41.1	33.9	20.7	35.0	54.1	27.2	33.0	28.8	47.3	83.8	27.5	53.2	93.2	27.3	117.1	44.0	10.6	19.0	5.3	22.1	20.3	16.6	13.4	12.0	19.3	28.3	15.1	15.7	18.0	3.8	30.6	16.7	18.2	23.4	18.3	20.4	20.4	21.6	27.8	21.2	21.7	22.9	21.2	22.7	19.5	20.3	20.8	7.1	0.0	5.9	4.6	10.7	6.6	6.8	9.2	9.1	14.1	11.5	11.4	5.9	17.2	8.9	12.9	12.5	20.5	21.3	12.3	7.9	16.0	25.5	6.3	11.8	10.2	15.0	13.7	4.0	10.7	20.3	10.7	12.2	9.6	1.3	11.1	8.2	52.4	20.7	5.0	5.0	10.9	6.1	15.6	6.0	47.9	10.2	9.2	5.4	0.0	14.9	16.4	20.6	5.0	5.5	10.8	10.8	8.2	10.3	12.4	10.4	12.3	4.5	17.9	13.1	7.4	9.1	22.0	31.0	10.0	10.1	13.0	10.3	16.5	17.3	5.5
ARNT	"bHLHe2, HIF-1beta"	ENSG00000143437	"Aryl hydrocarbon receptor nuclear translocator"	P27540	1	150809713-150876708	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"U-698: 397.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001759, CAB004318"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nuclear bodies"		"CAB004318: AB_626698, HPA001759: AB_1078213"	"unprognostic (1.81e-1)"	"unprognostic (8.14e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.27e-3)"	"unprognostic (5.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.67e-1)"	"unprognostic (6.45e-2)"	"unprognostic (6.92e-2)"	25.8	20.4	9.6	18.1	9.6	17.1	22.7	16.2	12.2	31.8	16.5	19.5	15.0	27.4	14.8	19.2	25.0	20.5	20.7	8.9	10.7	17.8	42.9	24.7	17.5	10.4	9.5	37.7	28.6	19.6	12.5	31.2	10.2	16.3	21.2	39.1	15.5	17.6	32.3	23.9	17.0	29.0	8.0	19.5	19.0	17.3	10.9	20.4	19.6	28.1	22.4	21.3	24.0	11.2	17.1	17.2	25.6	19.5	53.4	50.9	34.2	19.0	36.9	25.2	22.7	15.1	17.0	18.3	16.5	34.0	12.4	19.1	24.2	21.3	21.9	29.3	13.8	21.4	28.7	17.6	31.0	26.4	24.7	39.9	20.0	30.7	26.9	30.6	31.3	24.4	27.9	34.9	26.3	33.8	21.1	15.0	21.2	30.9	13.0	26.1	30.8	25.5	20.6	17.4	17.6	25.1	36.6	25.3	15.2	34.4	32.6	59.4	22.6	20.9	18.8	16.8	16.8	39.8	30.8	397.5	25.5	0.9	14.4	46.6	23.6	21.2	12.1	21.6	11.1	8.7	10.0	11.7	18.7	8.7	9.5	9.8	11.9	12.0	23.4	7.8	11.1	16.2	9.6	9.6	16.2	12.2	8.9	10.7	10.4	9.5	10.2	8.0	10.9	11.2	14.8	12.8	10.3	28.1	14.9	14.1	9.9	11.0	8.0	23.6	10.2	6.9	12.8	24.3	11.6	11.0	54.2	24.5	12.6	13.3	3.9	11.2	5.0	10.3	23.3	14.8	20.4	16.6	41.6	9.7	37.1	25.4	8.6	20.6	3.8	17.1	30.0	47.7	20.3	6.7	47.5	16.5	8.2	39.1	20.1	4.3	32.3	20.0	10.6	39.4	27.9	7.9	13.4	41.7	50.9	9.6	8.1	32.7	13.0	8.8	10.1	13.1	9.7	38.3	13.1	17.0	19.4	18.4	16.7	11.0	15.3	29.6	12.7	20.7	9.0	10.0
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.7;RPMI-8226: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	11.2	19.7	4.9	7.2	4.9	3.5	15.9	6.3	7.0	10.1	5.5	14.4	25.4	9.2	1.8	10.3	12.8	7.6	8.9	3.7	4.5	21.3	44.0	6.5	18.2	5.9	5.9	14.8	10.7	4.8	8.2	3.3	5.9	9.6	6.6	6.7	8.9	6.5	11.9	11.9	25.4	5.7	5.2	9.7	8.7	3.3	8.4	3.8	6.2	10.1	12.9	11.7	9.1	4.8	10.6	13.7	5.5	24.6	21.5	5.8	9.5	1.9	4.1	6.1	7.0	11.4	19.4	66.7	16.2	3.9	2.2	17.3	12.2	13.6	0.8	3.4	24.0	10.0	7.7	8.5	14.4	8.5	0.9	9.6	20.7	3.2	5.3	6.1	5.0	18.0	12.1	1.3	1.7	7.6	11.0	7.8	12.0	28.6	8.0	4.5	0.8	68.8	7.9	16.3	11.5	27.2	12.9	8.7	21.5	1.6	25.9	10.6	2.1	3.5	6.2	14.6	5.7	3.6	8.6	44.0	10.8	22.9	2.8	0.0	12.9	0.3	1.5	8.3	2.6	1.8	3.9	1.7	13.6	2.4	4.1	2.0	0.4	1.2	6.6	0.4	1.2	7.5	4.9	4.9	6.3	7.0	3.7	4.5	5.9	5.9	5.9	5.2	8.4	4.8	4.7	0.0	5.8	9.1	1.7	1.7	1.9	2.5	2.2	45.0	8.8	7.4	7.8	8.6	4.7	1.8	18.8	5.8	0.4	21.3	5.9	5.3	2.7	3.2	7.9	5.3	4.2	1.7	6.7	4.5	1.6	9.1	1.5	2.3	3.8	20.1	5.3	55.9	7.0	16.8	13.3	5.7	4.1	12.6	2.6	0.7	13.4	7.3	8.8	6.5	7.0	8.5	0.0	7.1	8.1	4.5	12.6	21.4	0.4	3.3	41.1	39.5	4.9	14.2	6.6	7.2	10.7	0.2	1.6	5.7	1.7	2.1	2.1	16.5	12.4	1.5
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1092.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.6	1.5	7.7	3.7	7.8	2.5	1.8	17.0	10.9	1.6	7.0	1.2	2.2	1.3	0.6	1.7	1.8	2.9	1.1	7.9	7.6	1.4	1092.3	3.9	1.3	8.0	8.2	1.1	0.9	7.0	2.9	0.5	8.3	1.7	0.5	4.8	0.9	0.3	1.5	4.4	1.4	1.3	6.0	4.8	1.4	26.5	7.8	0.4	5.8	0.4	0.3	1.7	1.5	8.7	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	7.7	7.8	17.0	10.9	7.9	7.6	8.0	8.2	8.3	6.0	7.8	8.7	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 721.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.5	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.4	0.1	0.5	0.4	0.3	721.0	0.4	0.0	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	1.0	0.5	0.4	0.4	0.3	0.5	0.1	0.3	0.8	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 525.1"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	30.4	11.6	9.3	2.7	7.4	0.0	4.7	7.5	12.0	22.0	5.0	36.1	4.7	41.0	24.3	25.8	36.2	6.0	9.7	7.9	7.3	4.9	525.1	10.9	0.2	7.9	9.4	3.7	2.3	0.1	1.8	0.0	7.8	12.5	16.1	8.8	1.9	32.3	2.7	8.7	10.6	29.7	7.4	5.9	3.5	1.3	12.2	2.9	1.3	5.1	0.1	11.3	5.1	9.4	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.4	7.5	12.0	7.9	7.3	7.9	9.4	7.8	7.4	12.2	9.4	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
BIRC2	"API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48"	ENSG00000110330	"Baculoviral IAP repeat containing 2"	Q13490	11	102347211-102378670	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005513, CAB020661"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"CAB020661: , HPA005513: AB_1846746"	"unprognostic (1.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.64e-2)"	23.2	27.6	18.4	25.8	19.6	36.4	28.2	20.0	23.4	27.5	22.5	27.2	23.6	25.7	30.2	18.1	19.7	24.8	23.6	17.9	19.9	28.8	44.3	22.6	34.5	19.7	19.4	21.8	33.7	20.4	18.8	29.4	19.8	21.4	26.0	22.2	21.1	16.1	29.7	18.2	25.2	21.6	20.1	26.7	23.5	24.6	18.8	50.6	22.2	32.9	27.1	30.4	20.4	24.9	34.0	24.7	37.3	29.3	46.1	63.3	23.9	128.3	48.8	71.9	43.4	30.9	81.7	37.1	123.5	59.2	40.3	36.7	24.5	33.8	85.7	50.0	12.6	37.2	17.6	37.8	46.9	22.9	23.0	40.8	64.4	41.2	52.3	66.2	50.1	22.2	34.4	0.2	131.0	10.9	24.3	20.1	18.1	40.1	23.7	11.9	48.4	24.9	55.4	38.5	15.5	20.3	44.7	26.9	40.7	56.7	42.5	27.3	82.7	150.7	34.4	46.2	84.2	14.9	21.9	25.0	32.6	28.2	112.5	97.2	43.3	104.4	22.9	42.2	18.9	15.7	21.5	21.3	33.8	15.1	27.4	27.7	67.6	34.3	46.7	20.4	33.2	27.5	18.4	19.6	20.0	23.4	17.9	19.9	19.7	19.4	19.8	20.1	18.8	24.9	61.8	41.7	41.1	17.0	52.6	67.2	109.2	53.6	39.9	24.4	52.3	52.8	58.6	67.2	49.5	64.4	29.2	38.4	77.9	85.7	43.0	49.8	20.8	63.2	54.0	51.0	48.5	80.0	22.4	73.7	27.8	55.9	28.5	85.7	62.7	43.7	59.3	182.1	41.5	20.2	21.7	54.3	46.8	84.3	71.5	11.2	36.4	71.1	51.6	26.2	81.2	34.3	55.6	21.6	33.1	54.5	71.1	29.0	49.2	75.0	82.1	110.1	56.6	31.0	26.3	45.7	48.9	44.7	42.4	28.4	62.8	35.2	57.1	36.4	44.2	82.5
C19orf12	"DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43"	ENSG00000131943	"Chromosome 19 open reading frame 12"	Q9NSK7	19	29698886-29715789	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 118.9;tongue: 105.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046930	Approved		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA046930: AB_10962836"	"unprognostic (1.76e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.94e-3)"	"unprognostic (7.93e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.22e-3)"	118.9	25.3	22.1	14.4	25.8	4.4	40.8	16.6	24.8	13.8	12.6	16.8	19.5	14.3	9.0	13.2	12.8	12.9	30.9	23.9	22.7	20.8	69.3	11.3	21.2	20.5	20.3	14.7	17.1	15.4	14.5	13.2	21.7	14.1	9.3	8.5	18.1	12.4	62.2	14.7	17.6	13.4	16.8	16.0	12.9	7.3	23.1	14.1	10.7	105.5	13.6	15.2	11.7	19.9	19.9	39.4	18.4	23.2	45.0	27.5	28.8	23.1	22.7	22.5	29.2	19.1	8.1	16.1	24.1	29.1	20.4	8.5	15.7	9.5	15.1	42.8	28.3	18.0	13.5	33.2	25.1	14.0	22.8	31.8	20.2	13.7	10.9	18.0	20.1	9.8	14.0	20.3	23.7	13.8	9.9	10.1	11.1	17.3	9.9	19.2	19.1	12.3	17.2	20.1	11.3	23.8	13.9	17.8	37.0	18.8	7.6	15.4	20.9	47.4	37.0	19.5	21.2	28.4	27.1	12.0	28.3	8.4	20.3	1.1	2.3	1.4	16.0	2.5	9.4	4.6	9.1	11.6	2.2	3.6	9.2	11.5	2.8	7.1	2.7	5.0	11.9	8.0	22.1	25.8	16.6	24.8	23.9	22.7	20.5	20.3	21.7	16.8	23.1	19.9	9.6	12.8	13.7	9.4	13.7	12.7	11.1	8.2	14.8	15.8	13.2	9.4	30.1	2.8	7.3	9.2	6.2	29.2	21.7	9.2	15.6	17.1	1.8	8.5	16.0	10.4	3.6	9.5	19.5	23.1	25.5	20.0	8.2	8.8	16.5	16.2	14.6	62.4	15.6	5.0	18.3	7.5	8.2	12.5	9.9	1.8	28.9	8.7	10.6	8.4	20.1	15.8	41.2	12.1	17.4	20.0	11.0	29.3	20.7	12.8	24.0	37.5	6.6	9.6	6.6	24.6	13.3	4.6	5.3	10.1	7.7	21.9	21.6	23.8	8.2	7.8
C1orf53		ENSG00000203724	"Chromosome 1 open reading frame 53"	Q5VUE5	1	197902630-197907367	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 64.6;Theca cells: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 8.9"	"Lineage enriched"	"Detected in many"	4	"monocytes: 8.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065352			Approved	Vesicles,Aggresome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Aggresome	"HPA065352: AB_2685477"	"prognostic favorable (1.63e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.37e-1)"	1.7	9.4	2.6	0.5	2.1	0.8	1.4	1.9	3.6	1.5	5.1	2.8	1.8	1.0	3.1	3.0	0.9	0.8	6.7	2.7	2.2	5.1	15.1	1.9	0.5	2.3	2.6	2.3	2.7	0.4	5.0	0.8	2.1	1.4	1.3	0.5	2.3	0.4	3.7	0.9	1.9	0.8	1.8	1.6	1.8	3.1	3.3	0.3	2.7	1.4	0.3	1.2	1.5	2.5	4.4	6.0	0.4	2.1	3.7	10.5	3.3	7.5	5.4	6.2	3.1	5.4	3.7	8.5	11.8	8.5	1.4	2.0	2.2	1.4	0.6	2.7	15.8	5.0	3.7	8.6	1.0	11.2	6.8	7.1	4.8	1.9	0.8	5.0	2.2	1.8	1.4	2.1	4.7	7.9	0.6	10.1	4.7	6.9	8.7	1.1	3.4	3.1	10.1	6.9	18.4	14.4	9.5	1.6	3.2	2.3	4.5	4.3	5.1	7.2	8.0	10.2	5.2	3.6	2.6	2.2	5.2	3.6	9.0	0.0	2.7	0.0	0.3	8.9	0.0	0.0	0.1	0.6	2.1	0.1	0.3	0.3	0.0	0.0	4.4	0.6	0.1	0.9	2.6	2.1	1.9	3.6	2.7	2.2	2.3	2.6	2.1	1.8	3.3	2.5	0.5	9.6	10.6	0.3	1.6	2.5	4.1	13.1	4.0	2.2	16.3	20.8	11.7	18.6	15.1	22.0	0.0	18.9	0.3	14.8	19.6	9.9	15.7	16.2	6.7	2.0	7.8	4.8	2.0	13.8	10.2	5.5	4.1	12.1	1.3	8.6	2.2	64.6	9.5	3.3	1.5	12.6	14.2	4.1	1.8	2.7	14.0	4.7	8.8	0.0	2.6	11.5	4.1	1.0	0.8	9.3	8.8	10.5	6.0	6.7	10.8	25.8	12.2	3.9	0.0	1.4	6.1	8.6	4.5	12.4	2.8	11.8	1.1	55.8	16.6	5.7
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109238	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 54.2;Hepatocytes: 140.0;Leydig cells: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.2;HSkMC: 43.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	15000000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	38.3	72.5	3.4	12.2	3.3	8.2	36.5	2.6	3.1	38.6	7.1	28.8	7.6	30.2	6.3	17.5	40.8	11.7	18.4	2.7	4.0	20.1	141.9	33.1	9.5	7.4	5.0	49.4	36.7	8.0	17.5	5.1	4.4	29.3	8.7	1.5	33.7	6.9	11.0	18.1	26.3	13.7	3.7	32.3	27.5	6.1	3.9	6.9	21.7	6.0	7.7	38.1	27.5	3.3	3.0	7.7	0.7	7.9	22.4	38.2	5.4	4.9	22.7	5.0	14.8	4.9	13.4	1.3	4.1	4.1	5.0	6.4	2.1	8.1	1.9	12.0	0.4	4.8	8.5	11.4	18.7	1.0	21.9	43.1	15.7	3.0	9.3	23.3	5.3	2.8	3.6	3.1	3.1	0.1	0.7	0.9	1.4	0.6	0.2	2.7	0.0	1.0	13.1	13.2	0.6	1.7	16.7	2.0	2.8	1.3	1.9	4.1	5.0	4.3	7.7	4.9	0.9	2.3	1.0	0.2	8.1	3.4	2.0	3.8	0.7	4.0	0.6	1.1	0.3	1.2	0.6	0.5	0.8	0.5	0.4	0.4	5.4	0.3	1.3	0.4	0.4	0.4	3.4	3.3	2.6	3.1	2.7	4.0	7.4	5.0	4.4	3.7	3.9	3.3	11.0	16.0	38.6	7.5	8.4	3.8	15.4	16.4	25.6	0.5	15.6	14.5	2.6	30.0	24.6	5.5	2.1	0.2	7.3	8.3	1.9	36.3	0.1	7.9	22.6	14.6	4.2	7.8	10.2	54.2	0.4	29.0	27.5	10.4	3.8	13.8	25.0	140.0	3.6	0.0	1.3	7.7	10.2	10.0	4.9	3.0	55.6	10.2	3.6	14.0	13.3	4.0	21.6	2.0	0.4	25.8	9.7	20.3	8.0	10.2	9.3	8.2	15.9	1.1	0.0	11.8	10.1	0.6	0.9	8.5	3.1	0.1	9.7	13.6	9.5	8.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C9orf64	MGC10999	ENSG00000165118	"Chromosome 9 open reading frame 64"	Q5T6V5	9	83938311-83956986	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054903, HPA066190"	Uncertain		Approved	"Golgi apparatus"		NA	NA		9400	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA054903: AB_2682636, HPA066190: AB_2685633"	"unprognostic (2.07e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.48e-3)"	8.1	9.2	4.7	8.4	5.6	2.3	7.9	5.1	5.6	8.9	11.0	7.9	23.6	10.2	11.3	5.9	11.4	6.3	8.4	4.8	5.8	13.5	24.5	8.8	8.4	5.7	6.0	10.9	6.1	14.0	4.6	8.0	5.7	8.8	8.2	5.5	6.6	8.7	7.7	4.3	22.1	10.4	5.3	6.6	9.7	8.2	5.5	10.0	16.1	7.1	8.1	7.7	4.9	6.7	23.4	19.7	0.3	0.1	9.9	13.4	23.7	15.0	4.3	14.2	15.8	17.9	20.5	0.1	12.5	16.9	5.7	14.2	0.0	0.5	18.4	25.2	13.1	10.4	25.6	34.9	22.8	0.0	30.1	15.4	19.8	13.6	0.0	3.2	9.3	0.1	25.3	0.3	17.4	23.0	4.9	0.8	18.7	14.8	9.6	0.1	29.9	1.1	11.4	3.7	19.2	18.9	27.0	6.4	21.1	0.3	8.4	20.1	2.9	1.7	20.0	31.7	4.4	6.3	0.3	0.9	13.1	0.8	10.2	7.0	10.4	9.8	6.5	11.8	6.2	2.4	4.9	6.6	11.9	3.3	5.3	6.3	4.2	12.6	12.9	8.3	5.8	4.6	4.7	5.6	5.1	5.6	4.8	5.8	5.7	6.0	5.7	5.3	5.5	6.7	6.5	12.8	10.8	2.0	3.6	2.2	4.5	5.2	4.0	4.3	5.5	4.2	5.4	4.3	3.3	3.7	4.2	12.7	4.1	6.2	11.7	11.6	6.7	11.1	9.0	5.4	4.2	3.4	2.6	8.7	19.4	8.5	8.6	8.4	9.5	6.0	4.6	24.7	12.3	3.3	2.9	7.2	14.2	12.8	4.6	2.9	8.1	8.7	1.8	1.9	13.2	11.9	7.2	3.0	3.8	10.6	10.4	10.9	3.6	3.7	22.1	17.3	6.5	7.3	0.0	11.3	6.7	9.6	5.5	3.7	1.4	4.4	4.2	10.7	10.5	3.0
CCDC25	FLJ10853	ENSG00000147419	"Coiled-coil domain containing 25"	Q86WR0	8	27733316-27772653	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023256	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA023256: AB_2072067"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (1.11e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	14.0	20.9	10.1	11.8	11.4	4.9	17.4	10.5	17.1	10.1	7.3	14.3	35.5	10.4	14.3	14.2	12.9	11.9	12.2	9.9	11.3	22.5	32.3	8.8	14.0	11.1	10.5	10.8	16.3	18.3	7.5	10.6	11.5	11.6	15.7	11.1	13.5	12.0	28.4	10.3	30.8	10.3	11.3	10.5	20.0	10.9	11.9	11.4	18.8	15.2	14.2	11.7	9.4	13.0	50.1	27.9	25.8	24.7	22.8	33.0	17.2	41.0	39.5	24.7	24.0	11.2	17.9	53.6	27.7	20.9	21.2	23.1	23.6	40.0	35.5	20.3	16.4	66.9	23.1	19.3	36.9	23.8	20.8	37.1	25.9	27.1	37.6	28.7	54.0	33.7	32.2	24.6	27.8	19.2	55.3	19.9	37.9	49.4	14.8	18.7	44.4	28.8	32.3	26.7	15.1	41.7	27.5	21.0	42.8	19.0	24.0	13.1	44.6	22.5	33.4	38.9	21.7	24.5	33.8	19.5	35.0	30.8	23.8	20.3	8.9	6.6	15.2	12.6	17.8	19.8	19.6	16.1	11.6	15.5	18.3	19.3	3.2	14.3	13.4	18.1	23.2	10.4	10.1	11.4	10.5	17.1	9.9	11.3	11.1	10.5	11.5	11.3	11.9	13.0	47.5	25.6	38.9	12.4	34.8	21.4	39.6	46.5	55.2	42.6	57.3	61.6	62.5	60.1	44.5	53.3	12.5	77.6	31.2	61.6	109.5	76.9	183.1	46.8	51.0	54.2	26.5	46.7	30.5	134.6	56.0	49.3	63.2	33.3	63.9	39.3	55.0	144.5	44.7	55.5	21.9	58.6	46.8	33.5	27.2	162.9	47.2	27.4	37.4	12.2	44.4	60.2	35.0	12.1	17.7	83.7	51.1	47.4	40.7	55.2	182.1	128.6	53.7	38.9	46.0	44.4	49.1	91.1	59.6	56.7	22.3	42.4	38.7	88.1	71.2	36.0
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"liver: 120.3"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 262.0"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 10.1"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	2780000	23000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.2	0.5	0.2	0.2	0.0	0.0	0.3	120.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	262.0	0.0	0.0	0.0	0.2	0.0	4.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"epididymis: 67.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Collecting duct cells: 5.5;Excitatory neurons: 1.4;Hepatocytes: 6.9;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 4.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	46	"U-266/70: 7.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"							"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.6	0.1	0.1	0.2	0.0	3.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIDEB		ENSG00000136305	"Cell death inducing DFFA like effector b"	Q9UHD4	14	24305096-24311430	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 310.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 258.9;Proximal enterocytes: 301.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HEL: 11.0;Hep G2: 24.0;HL-60: 15.5;Karpas-707: 10.6;U-266/84: 14.8;U-937: 17.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA001272	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001272: AB_2666255"	"unprognostic (2.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.35e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.64e-1)"	13.2	37.2	1.6	5.6	1.6	12.3	11.6	2.3	2.2	17.3	2.2	10.7	70.6	8.6	4.4	35.5	12.9	3.8	7.5	1.5	2.2	31.1	310.8	10.5	4.8	2.0	2.0	25.3	19.3	1.9	12.2	2.0	1.9	11.2	3.5	0.2	14.2	4.8	2.5	22.6	58.1	4.0	1.9	88.9	8.0	2.2	2.6	3.6	7.6	1.3	7.2	8.6	20.1	1.9	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.4	0.1	0.2	0.1	1.4	0.5	0.0	0.0	0.6	0.0	2.0	0.0	0.2	0.0	21.5	0.0	11.0	0.0	24.0	0.1	15.5	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.0	0.0	10.6	0.0	0.0	0.1	7.3	0.0	5.6	0.0	1.8	0.1	5.5	0.0	0.7	4.5	0.0	5.9	0.1	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	8.4	14.8	0.1	0.0	17.9	0.0	0.9	5.2	6.9	3.4	1.8	3.2	0.5	2.2	2.1	5.2	0.4	1.4	1.7	2.9	5.2	0.9	1.3	1.3	2.0	1.6	1.6	2.3	2.2	1.5	2.2	2.0	2.0	1.9	1.9	2.6	1.9	8.8	0.0	1.7	0.0	6.9	7.0	6.4	5.6	29.6	0.4	4.6	5.6	0.0	11.5	3.3	1.8	2.1	0.1	15.0	14.4	9.8	1.5	0.1	4.3	2.0	7.0	1.8	13.0	0.0	9.6	0.2	4.0	5.1	1.2	8.8	0.3	12.5	258.9	7.9	0.0	0.1	11.7	8.2	30.5	2.6	0.5	6.2	13.2	5.4	1.0	8.8	0.6	21.6	0.0	0.1	15.4	24.4	3.0	7.2	0.7	301.5	51.6	10.5	0.6	0.0	0.9	2.8	0.2	2.3	33.4	6.1	0.3	11.1	3.6	8.6	1.8
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"kidney: 13.8;liver: 39.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Distal tubular cells: 19.6;Ductal cells: 11.8;Exocrine glandular cells: 8.2;Hepatocytes: 22.2;Pancreatic endocrine cells: 21.3"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"HDLM-2: 224.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.3	0.1	0.1	0.0	13.8	39.5	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.2	0.1	0.0	0.1	0.3	0.2	0.0	0.4	0.4	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	224.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.7	2.1	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.5	15.8	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.1	7.4	4.2	0.1	0.7	0.4	6.7	15.7	0.0	1.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	1.0	0.6	0.0	0.0	0.8	0.4	0.7	7.2	0.1	1.8	0.0	0.1	0.0	0.7	19.6	11.8	0.6	0.3	0.2	3.6	0.0	0.0	0.6	8.2	1.3	0.1	0.0	3.4	0.0	0.0	0.4	22.2	0.1	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.2	3.6	0.0	0.6	0.0	0.0	1.5	1.0	21.3	0.0	0.4	6.9	0.6	0.0	0.7	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.3	0.8	1.4	0.0	0.3	2.3
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1484.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.5	0.1	3.1	0.7	0.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	4.8	0.0	0.5	1.4	0.4	1484.1	17.6	0.1	1.7	2.0	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.6	1.8	0.5	1.4	1.7	2.0	2.5	0.3	2.2	5.1	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 218.6"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.0	0.7	0.4	0.6	1.5	0.2	0.6	1.1	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.7	0.8	14.7	218.6	0.2	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.4	0.2	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.7	0.8	0.2	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1063.2"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000		"Cluster 85: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.5	0.4	1.0	0.4	10.0	0.1	1.5	4.9	1.7	0.9	0.1	0.8	211.8	1.6	2.8	1.5	0.9	1.6	1.2	0.7	2.3	1.9	1063.2	1.0	0.3	6.9	8.7	2.9	0.8	0.1	0.9	2.5	6.0	0.8	0.4	0.3	0.5	0.8	0.6	1.4	123.4	2.1	3.4	1.2	0.6	6.0	5.8	0.3	1.7	0.5	0.2	0.6	0.7	6.3	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.0	4.9	1.7	0.7	2.3	6.9	8.7	6.0	3.4	5.8	6.3	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 122.9;ovary: 34.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	4.3	12.9	3.4	1.3	3.1	3.4	2.9	3.3	4.0	2.5	4.5	5.1	5.2	2.2	1.6	4.5	3.8	1.8	2.4	3.3	3.6	13.5	122.9	3.1	0.9	3.4	3.7	34.4	17.0	1.4	2.9	1.1	3.4	4.3	6.2	8.1	2.5	2.1	3.6	1.2	5.3	1.3	2.7	1.0	7.4	4.1	3.7	0.6	7.7	2.9	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.1	3.3	4.0	3.3	3.6	3.4	3.7	3.4	2.7	3.7	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748845-74756607	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	313	"liver: 513.4"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 85.7"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.2	0.3	0.5	0.2	0.5	1.0	0.1	1.6	0.8	0.0	0.2	0.0	0.2	0.2	0.4	0.1	0.2	0.2	0.1	0.5	0.5	0.2	513.4	0.4	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.7	0.6	0.1	0.1	0.4	0.2	0.3	0.3	0.6	0.2	0.0	0.1	0.3	0.2	0.3	0.6	0.1	1.4	0.0	0.1	0.1	0.0	1.3	0.4	0.3	0.8	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.4	0.8	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.3	0.1	1.3	0.7	1.3	0.0	0.2	0.9	0.3	0.4	0.3	0.2	0.9	0.8	0.3	0.1	0.7	0.7	0.3	0.6	2.3	0.1	0.6	0.5	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.5	0.3	0.9	0.3	1.5	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.2	2.1	0.4	0.2	0.4	0.1	0.1	0.5	0.5	1.6	0.8	0.5	0.5	0.6	0.5	0.6	0.1	0.6	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.7	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683729-94736190	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.8;liver: 197.0;stomach 1: 67.2"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;OE19: 1.9"	"Not detected"	"Not detected"							HPA074424			Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA074424: "	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.3	0.0	0.0	1.6	0.1	0.0	0.3	0.2	0.1	5.3	0.0	5.9	102.8	0.1	0.0	30.9	0.0	16.3	0.0	0.1	0.0	0.3	197.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.5	0.0	5.4	0.0	0.0	4.4	83.1	0.1	0.1	0.0	67.2	0.1	0.1	0.3	0.0	0.0	7.1	0.2	9.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.3	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.1	17.2	3.2	0.0	0.0	0.1	0.0	6.7	0.0	1.5	0.0	0.6	0.1	0.0	0.0	2.7	0.5	6.9	0.2	0.1	68.8	1.3	0.0	0.0	1.8	124.0	0.0	0.0	0.8	2.1	2.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	3.9	0.0	0.3	0.0	62.5	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	22.8	1.7	1.5	0.1	0.1	5.7	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94855547	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 190.2"	"Group enriched"	"Detected in some"	11	"Gastric mucus-secreting cells: 3.1;Hepatocytes: 9.5;Proximal enterocytes: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, HPA074424"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA015066: AB_1847433, HPA074424: "			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.2	0.2	0.1	0.2	32.4	0.0	0.1	1.6	0.0	1.7	0.0	0.1	0.0	0.0	190.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.6	13.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	3.1	0.0	0.0	0.0	0.4	9.5	0.0	0.0	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2156.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.3	1.8	1.7	0.0	1.9	0.2	0.3	1.4	2.1	0.3	1.4	0.4	0.2	0.1	0.3	0.1	1.1	4.6	0.3	1.8	2.2	1.4	2156.6	0.4	0.1	1.7	2.2	0.1	1.7	0.5	3.1	0.1	1.8	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.4	1.0	6.0	4.0	2.1	0.2	0.9	0.0	0.1	0.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	1.4	2.1	1.8	2.2	1.7	2.2	1.8	1.4	2.1	1.8	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1719.9"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	1.2	0.0	2.7	87.8	0.0	0.0	7.7	0.0	7.9	0.0	0.0	0.0	4.3	1719.9	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.2	0.1	0.0	0.5	18.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130865	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 320.0"	"Group enriched"	"Detected in many"	35	"Hepatocytes: 512.8;Proximal enterocytes: 465.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.8"					"Low region specificity"	"Detected in many"			HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.2	0.0	0.3	0.3	0.1	0.8	0.2	0.1	0.3	0.3	3.7	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.3	320.0	0.1	0.1	0.2	0.0	0.2	0.8	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	11.7	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.0	1.1	5.5	0.7	0.5	0.7	1.3	2.8	7.3	1.1	1.4	0.4	2.8	0.7	1.8	2.1	0.1	0.6	2.9	1.9	0.7	3.1	0.8	0.6	0.6	1.2	0.0	6.5	0.6	0.1	0.3	4.1	1.4	0.0	0.7	5.7	512.8	0.1	11.8	9.4	7.6	0.0	5.6	0.0	13.6	0.0	0.4	0.0	0.0	0.1	0.7	0.0	5.0	4.9	0.7	11.3	1.5	0.4	0.6	465.2	0.5	1.3	2.3	0.0	0.4	2.1	0.8	0.4	0.6	1.1	0.4	1.0	0.1	3.4	0.3
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	309	"liver: 10379.8"	"Cell type enriched"	"Detected in many"	58	"Hepatocytes: 6272.7"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5;myeloid DC: 6.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 6.2;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	2.8	2.9	5.4	0.6	5.4	0.8	3.0	9.1	7.5	4.9	3.0	5.0	1.4	4.5	8.3	16.7	5.5	2.5	2.1	5.5	5.5	9.1	10379.8	2.6	2.0	6.1	5.5	4.1	12.4	0.6	4.1	1.4	6.7	5.3	1.2	11.5	3.6	6.1	2.8	13.8	2.2	2.2	5.0	7.2	6.7	3.7	6.3	1.7	4.0	0.9	33.6	3.5	3.2	7.5	0.1	0.0	0.3	1.0	3.5	1.9	0.7	1.6	4.5	0.0	0.3	0.0	2.7	1.4	0.2	0.5	0.0	11.0	0.0	0.2	0.4	0.3	1.5	1.8	0.2	1.3	0.6	8.9	8.9	1.0	0.2	0.0	0.7	1.9	0.0	3.1	0.6	0.4	1.0	0.7	0.6	24.0	6.4	4.3	0.4	0.4	6.1	0.0	2.0	0.0	0.0	0.0	4.2	0.0	0.6	0.2	0.3	0.9	0.0	1.4	0.4	2.3	1.0	2.2	1.0	3.0	1.5	7.4	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.6	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	5.4	5.4	9.1	7.5	5.5	5.5	6.1	5.5	6.7	5.0	6.3	7.5	0.8	0.0	1.1	5.5	9.2	2.3	0.2	0.7	0.6	5.7	0.6	0.5	2.8	48.6	1.9	0.0	2.1	0.0	0.4	0.1	0.0	1.6	2.1	0.6	0.8	4.6	0.0	67.6	6.7	1.3	0.1	1.1	1.5	0.5	1.3	0.7	67.1	6272.7	0.0	8.4	5.3	0.0	0.0	108.0	2.8	2.1	1.5	0.3	0.0	1.9	0.4	0.7	0.0	2.0	2.2	3.2	0.0	2.6	0.3	0.6	0.0	0.6	2.2	5.8	0.0	0.2	0.6	4.1	4.2	2.0	7.5	0.1	5.7	0.2	0.0	0.0
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 99.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 62.9;Late spermatids: 20.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;hTCEpi: 13.6;OE19: 6.1;SiHa: 8.4;U-698: 10.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 22.9"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	3.0	2.5	2.1	1.0	2.7	0.0	5.4	3.5	2.9	3.7	5.3	2.7	0.8	3.6	21.0	3.3	4.1	6.3	3.9	2.0	2.1	5.7	99.2	3.3	0.5	2.3	2.3	11.5	5.7	15.3	2.9	0.4	2.1	14.8	3.6	4.1	23.5	2.6	0.6	15.9	1.6	2.4	2.4	0.7	2.8	4.2	2.4	0.4	6.1	1.2	1.4	2.7	3.0	2.9	0.2	0.4	0.3	1.8	0.3	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.5	6.5	4.4	0.0	0.9	1.7	0.8	1.4	0.0	0.0	2.8	0.0	1.7	1.8	4.0	0.0	0.0	0.5	13.6	0.0	1.6	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	1.5	0.5	1.1	0.1	2.9	4.0	0.7	0.0	8.4	0.0	0.2	0.4	1.5	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.5	2.9	2.0	2.1	2.3	2.3	2.1	2.4	2.4	2.9	3.3	16.0	1.5	3.9	0.2	4.0	8.8	2.7	2.8	1.4	4.6	6.5	5.8	10.0	4.3	3.7	2.1	0.0	0.0	1.1	5.9	2.9	12.7	4.4	1.0	3.5	0.0	5.3	3.2	0.4	0.9	4.5	1.5	3.1	0.0	2.7	1.1	62.9	0.2	0.0	2.0	4.0	10.2	2.5	0.9	20.1	6.2	0.3	3.6	8.4	0.0	8.6	0.0	1.0	7.2	0.5	2.7	9.4	0.0	7.9	0.3	5.3	7.2	1.5	0.0	1.9	2.3	0.7	0.8	2.6	15.3	0.0	0.2	6.3	2.5	8.1
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149735	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 214.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 143.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"															NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.1	0.0	32.9	214.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	143.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 80.2;liver: 235.8"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 562.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	63	"neutrophil: 84.1"	"Lineage enriched"	"Detected in single"	177	"granulocytes: 84.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058960	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	1.6	0.1	0.9	1.2	3.3	80.2	0.2	2.3	1.3	6.9	0.3	2.1	9.4	0.1	0.8	26.7	1.1	15.5	0.3	1.8	2.2	27.3	235.8	2.3	0.1	2.8	3.0	0.0	0.6	0.0	0.5	0.4	2.9	0.6	1.8	0.0	3.4	0.6	0.1	3.9	15.0	0.3	1.9	7.8	5.1	0.3	1.9	0.7	0.1	0.6	0.7	2.9	9.0	4.1	0.3	7.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.0	0.1	14.9	0.0	0.2	0.0	0.6	0.0	0.1	3.5	18.3	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	49.3	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	84.1	0.0	0.1	0.0	0.0	0.1	0.9	3.3	2.3	1.3	1.8	2.2	2.8	3.0	2.9	1.9	1.9	4.1	0.0	9.6	3.7	0.7	2.0	1.0	2.1	2.5	1.2	0.0	0.1	0.1	0.9	62.9	5.0	0.0	0.0	0.0	1.4	10.0	0.0	2.3	0.1	0.9	0.2	0.7	53.1	17.3	0.0	0.2	0.2	0.8	7.7	3.1	1.3	0.0	8.2	562.4	0.0	0.0	0.0	14.4	8.2	11.4	0.3	0.7	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.0	7.4	0.0	0.0	3.2	69.9	32.1	1.9	0.0	0.0	0.7	1.3	0.0	0.3	25.7	6.5	0.0	1.1	0.0	10.9	13.1
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191567-186213463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.2;SK-MEL-30: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	7.4	16.4	5.1	5.2	6.8	2.1	5.7	5.6	5.0	8.6	17.9	9.6	16.5	5.6	2.6	5.0	6.1	14.7	9.2	4.8	5.1	33.9	113.5	10.8	5.6	5.3	6.0	5.7	15.6	33.4	3.7	3.5	5.3	8.2	11.9	14.2	7.0	7.5	4.5	1.3	16.7	7.1	5.4	11.2	6.2	3.2	5.6	6.5	17.3	5.0	4.9	6.4	2.3	6.3	3.4	1.8	0.8	0.0	15.2	6.3	0.2	4.4	9.9	1.7	1.9	0.0	13.0	1.1	0.5	3.5	5.9	1.6	1.9	1.7	0.3	6.0	2.2	4.7	0.8	0.5	5.6	2.6	1.9	5.8	0.8	1.9	1.0	5.9	0.1	6.4	1.4	14.3	6.8	2.9	3.6	1.3	1.5	1.6	0.0	3.1	0.7	1.0	7.4	6.1	4.0	4.9	1.1	0.0	27.5	0.3	2.6	4.6	4.1	3.6	0.7	3.5	1.6	0.1	0.0	0.5	10.9	11.0	4.7	0.0	0.6	0.0	1.8	1.9	1.0	0.4	1.4	1.8	0.7	1.0	1.3	1.3	0.0	0.8	3.1	1.3	1.1	0.9	5.1	6.8	5.6	5.0	4.8	5.1	5.3	6.0	5.3	5.4	5.6	6.3	9.0	6.4	11.5	31.3	13.8	2.5	4.5	5.1	9.6	33.6	9.3	7.2	18.8	42.9	8.7	14.7	31.3	2.0	9.6	14.7	9.8	24.2	2.7	6.7	5.1	7.7	16.9	16.4	15.4	22.4	2.1	14.2	12.8	7.6	7.0	6.5	8.9	103.7	13.5	5.0	23.4	16.5	2.0	14.8	6.0	2.1	5.0	11.3	3.6	6.5	3.5	52.2	4.1	15.6	11.0	9.6	9.0	6.4	12.3	3.8	47.2	28.5	11.9	27.4	0.0	10.1	10.6	8.9	6.3	6.8	3.1	1.0	17.2	6.7	10.5	5.7
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	80	"liver: 49.5"	"Cell type enriched"	"Detected in single"	17	"Hepatocytes: 7.0"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42875898	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 404.5"	"Cell type enriched"	"Detected in some"	76	"Hepatocytes: 920.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;SK-BR-3: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.3	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.5	0.1	0.2	0.1	14.4	404.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	1.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.9	920.2	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0
DDT	"D-DT, DDCT, MIF-2, MIF2"	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23979828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 835.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 4869.6;Proximal tubular cells: 1415.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 262.9"									"HPA049871, HPA074115"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA049871: AB_2680926, HPA074115: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	125.7	126.7	29.6	15.1	30.6	39.6	99.0	33.1	38.0	69.6	28.7	128.5	44.2	62.6	16.2	119.1	67.3	6.3	167.0	28.9	32.2	218.2	835.9	69.2	13.7	30.7	29.6	83.0	260.9	24.3	47.7	10.7	30.7	109.0	24.2	12.8	82.7	15.7	129.3	89.8	120.7	8.6	30.7	66.3	176.2	39.2	32.9	12.3	80.1	15.7	11.9	86.8	76.4	33.9	107.6	44.8	15.4	34.9	29.0	24.9	92.6	30.4	20.7	26.1	27.1	39.8	30.6	101.9	27.8	16.1	37.7	86.3	38.3	38.1	17.1	43.6	262.9	60.8	58.9	88.3	28.9	136.2	58.8	25.5	28.5	26.3	23.1	27.9	28.7	16.0	56.8	40.2	26.9	53.0	30.1	123.1	46.2	94.4	134.2	65.3	27.0	148.9	46.4	39.2	51.7	49.2	62.8	117.7	95.9	20.6	30.8	42.3	33.1	26.8	59.9	27.8	32.2	122.6	43.9	65.1	53.1	49.7	52.5	63.5	92.9	72.4	46.0	82.8	47.5	75.3	55.3	49.1	87.8	70.7	49.2	48.9	58.3	61.6	79.1	130.4	74.5	78.8	29.6	30.6	33.1	38.0	28.9	32.2	30.7	29.6	30.7	30.7	32.9	33.9	116.9	83.3	86.3	11.1	178.3	138.9	220.5	278.8	176.4	58.4	266.6	379.7	21.3	499.0	153.2	242.8	89.6	202.6	134.1	533.1	718.1	237.2	202.1	150.8	126.4	103.4	259.6	230.2	9.1	375.7	288.2	103.9	163.1	260.3	129.4	97.1	154.9	4869.6	281.0	43.7	11.0	402.8	187.2	240.4	162.2	411.0	117.1	172.2	158.3	9.4	235.8	119.6	135.9	6.0	18.8	233.6	395.1	110.6	166.1	257.5	935.1	1415.8	97.6	100.0	78.9	109.5	127.6	117.9	43.8	280.6	188.0	299.8	140.3	212.5	558.7	291.3
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
DNAJC25	bA16L21.2.1	ENSG00000059769	"DnaJ heat shock protein family (Hsp40) member C25"	Q9H1X3	9	111631334-111654351	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 32.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA019122	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA019122: AB_1853155"	"unprognostic (3.07e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.94e-3)"	"prognostic favorable (3.73e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.81e-2)"	"unprognostic (9.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.52e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.19e-2)"	3.3	5.2	1.0	2.3	1.1	1.0	2.0	1.0	1.9	1.5	2.5	3.0	2.9	1.7	4.4	1.5	1.8	2.1	2.5	1.1	1.0	5.1	32.1	1.3	0.7	1.4	1.2	1.4	2.9	4.2	1.5	2.7	1.2	3.7	1.6	0.6	4.2	2.2	2.2	1.0	2.4	1.7	0.9	0.7	2.4	1.4	1.0	0.2	2.2	1.7	0.8	3.0	1.3	1.0	2.7	2.0	1.3	2.3	14.1	6.2	5.3	10.4	4.8	3.9	3.7	3.7	1.6	2.4	4.0	7.0	6.1	8.5	1.5	2.9	3.7	1.9	2.0	2.4	0.0	8.0	4.5	4.5	3.3	5.3	8.2	3.0	5.6	3.0	3.3	1.3	4.9	1.8	5.0	2.9	1.3	0.2	2.3	5.1	4.9	2.3	7.3	2.2	8.2	2.8	2.3	1.2	5.7	7.7	3.6	2.3	4.1	0.8	6.5	4.7	2.3	12.9	6.0	3.6	6.0	1.3	8.1	2.1	4.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.0	1.1	1.0	1.9	1.1	1.0	1.4	1.2	1.2	0.9	1.0	1.0	9.9	6.4	11.9	0.0	8.3	10.6	16.2	13.8	6.8	7.9	14.1	12.4	13.9	8.6	16.0	11.0	20.9	14.2	16.7	16.2	13.7	17.1	10.8	18.6	18.2	7.9	17.3	3.0	0.0	16.3	24.7	15.3	10.2	19.5	1.3	8.8	6.4	85.3	12.1	13.5	0.0	21.3	6.1	6.4	10.2	2.5	10.2	10.0	12.4	0.0	6.7	4.6	5.2	0.0	0.0	11.7	7.3	10.1	22.6	29.4	21.7	13.5	18.9	19.9	13.1	13.3	15.7	29.5	16.6	7.0	9.2	13.8	8.8	10.6	15.0	22.7
ECHDC2	FLJ10948	ENSG00000121310	"Enoyl-CoA hydratase domain containing 2"	Q86YB7	1	52895910-52927212	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 174.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 875.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;HHSteC: 11.0;THP-1: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026731, HPA026768"	Enhanced		Approved	Mitochondria		NA	NA		240000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA026731: AB_1847969, HPA026768: AB_1847970"	"unprognostic (2.73e-3)"	"unprognostic (1.52e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.76e-1)"	"unprognostic (7.67e-2)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.11e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.62e-1)"	"prognostic favorable (2.70e-4)"	24.1	35.2	5.9	1.2	6.0	2.7	24.9	7.5	7.9	18.1	7.2	18.0	16.7	17.2	5.5	28.2	23.1	5.1	27.6	5.6	5.7	50.6	174.3	12.8	2.3	5.6	5.8	29.1	23.2	14.3	14.6	4.5	5.7	24.0	3.5	5.0	19.0	8.4	29.9	17.1	17.3	2.4	5.5	9.3	29.1	7.0	6.1	3.0	38.9	26.8	1.5	18.2	16.8	5.7	0.0	1.8	0.0	0.0	1.1	0.5	15.8	1.2	7.6	1.6	2.4	0.0	1.5	0.0	7.7	1.2	0.0	0.8	0.0	1.2	0.3	0.0	8.1	0.0	3.1	3.6	11.0	0.0	1.8	1.6	3.2	1.0	1.1	2.4	4.5	0.0	1.2	0.2	0.0	4.2	0.0	0.9	0.2	7.0	1.7	0.0	0.2	0.7	5.2	6.4	0.8	0.3	2.3	6.3	0.1	0.9	1.3	10.2	2.3	0.0	0.0	0.7	0.2	0.3	0.6	0.0	0.5	0.0	0.4	0.0	2.1	1.8	12.1	1.4	9.1	6.9	9.9	11.4	9.5	3.3	10.7	6.6	0.4	6.1	0.8	2.4	13.6	4.0	5.9	6.0	7.5	7.9	5.6	5.7	5.6	5.8	5.7	5.5	6.1	5.7	23.9	54.5	92.0	161.3	17.9	30.7	85.6	67.2	83.1	32.3	96.4	86.7	61.5	153.0	71.1	86.5	327.4	206.0	26.7	96.4	178.1	59.3	150.2	54.9	19.5	18.7	52.1	29.9	26.0	59.4	18.0	64.6	94.3	41.3	29.8	50.6	30.4	875.3	31.8	42.1	34.9	78.3	40.7	27.6	13.8	180.6	154.1	12.8	40.9	51.5	7.6	60.0	23.7	54.8	6.9	44.6	115.7	112.5	10.0	66.5	172.6	284.7	62.5	160.6	19.7	118.3	39.5	17.0	16.7	66.9	29.5	124.0	36.1	23.7	64.7	80.0
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810124-225845563	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1178.6;liver: 1705.1"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1161.8;SiHa: 413.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	245.8	1178.6	233.5	23.6	252.5	22.7	163.7	239.0	249.3	188.3	345.8	82.0	102.2	108.1	97.6	159.6	153.8	96.5	94.0	221.3	233.7	110.7	1705.1	146.8	39.1	225.3	234.9	329.1	536.1	147.7	105.8	32.9	223.6	113.2	52.5	30.7	143.6	128.1	142.5	71.5	52.8	109.6	210.1	55.7	99.9	74.3	258.4	25.9	171.1	95.6	33.4	135.4	140.4	227.2	32.1	202.3	12.3	108.5	1161.8	120.2	24.3	29.7	49.2	28.1	35.1	38.8	293.6	1.3	128.7	147.3	30.6	38.1	32.7	16.8	12.1	7.8	46.5	21.8	83.5	282.7	129.8	12.9	15.1	109.2	40.0	74.6	6.3	116.5	22.1	13.4	14.5	27.3	50.4	30.3	13.5	31.0	61.6	178.1	79.4	27.8	15.2	92.9	91.1	132.5	98.3	13.0	413.0	192.1	51.3	32.1	131.7	43.5	46.8	41.9	35.4	54.5	59.0	9.1	38.9	4.1	63.5	14.2	59.5	0.0	2.6	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.6	0.2	0.5	0.3	0.2	0.7	0.3	0.9	0.3	0.8	233.5	252.5	239.0	249.3	221.3	233.7	225.3	234.9	223.6	210.1	258.4	227.2	196.9	0.0	14.0	41.1	5.7	19.6	121.8	244.2	74.0	8.8	29.7	27.4	1.2	102.9	255.5	51.5	29.2	46.6	3.4	34.5	17.6	95.3	10.2	142.9	32.2	82.7	10.8	7.0	3.1	73.0	7.6	175.6	30.5	93.4	5.7	349.9	88.2	757.6	149.1	1.7	5.0	17.5	103.7	30.9	28.7	28.4	311.3	25.8	42.7	23.4	9.6	99.2	0.0	7.1	19.4	45.5	27.2	159.1	9.5	40.4	63.4	128.9	174.3	10.1	223.5	29.3	146.9	4.4	5.1	129.0	17.6	22.8	4.7	1042.6	31.5	108.5
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 159.2;Hepatocytes: 266.3;Proximal enterocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"	27.3	35.5	25.5	15.8	29.8	16.3	23.6	36.4	31.4	17.5	33.6	67.6	81.8	15.5	4.7	62.7	14.6	10.2	154.9	23.5	31.6	70.3	91.5	30.9	11.0	30.9	31.7	8.1	56.3	23.9	15.9	15.4	29.8	26.4	22.9	5.1	48.5	12.6	195.3	35.9	65.4	7.1	26.6	32.0	52.4	8.4	37.5	8.4	28.3	88.8	12.4	31.0	28.8	23.7	25.9	40.2	9.8	23.6	13.0	12.7	54.2	25.0	11.9	9.2	9.0	37.4	30.3	34.9	45.1	12.8	23.7	66.0	16.9	33.0	3.5	23.0	21.0	22.9	51.7	30.1	18.0	39.3	55.3	17.4	49.8	20.7	27.0	12.8	12.8	18.1	37.9	18.7	15.3	57.9	19.4	55.9	27.9	30.4	74.4	20.4	19.7	79.6	31.1	52.4	20.6	26.2	12.8	81.2	83.8	5.5	25.8	38.2	28.9	16.6	20.4	47.4	25.6	28.6	25.5	23.6	26.9	38.2	13.4	0.2	2.9	4.8	2.7	5.4	2.6	1.7	2.3	1.9	2.7	2.3	2.3	3.3	5.3	1.8	5.1	2.1	3.6	1.7	25.5	29.8	36.4	31.4	23.5	31.6	30.9	31.7	29.8	26.6	37.5	23.7	20.8	9.6	22.7	21.2	14.7	18.6	41.0	29.7	18.8	28.8	30.9	24.3	9.2	100.1	21.3	20.2	33.3	103.8	20.9	159.2	54.8	51.3	3.4	18.7	17.4	15.3	37.8	19.4	13.6	80.2	61.3	12.4	39.8	20.3	7.6	9.3	35.0	266.3	33.6	33.7	16.6	82.5	28.5	82.7	11.7	1.1	6.5	22.2	17.8	11.2	28.8	20.1	27.8	9.0	6.4	81.1	103.1	12.0	8.2	42.8	199.7	82.2	19.8	20.4	13.1	18.7	21.7	3.5	7.1	26.3	18.5	134.2	14.5	22.2	113.7	65.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.4	0.1	1.4	0.1	1.2	2.6	0.3	0.1	1.3	0.4	0.1	0.5	0.5	0.2	0.0	1.9	0.3	0.1	0.4	1.5	0.8	0.8	604.6	0.6	0.0	0.8	0.6	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.4	1.0	0.1	1.2	0.8	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.4	1.2	0.1	1.3	1.5	0.8	0.8	0.6	0.9	0.4	0.8	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	211	"liver: 200.2"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 54.9"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	200.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	54.9	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 142.8;liver: 176.2;placenta: 46.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.3	3.2	1.4	3.7	0.6	4.4	1.3	0.1	142.8	0.3	0.9	0.1	0.2	0.2	3.5	17.6	2.7	4.4	1.6	1.5	176.2	0.9	2.2	1.9	2.2	0.0	0.8	0.0	1.6	46.9	2.4	1.3	0.6	1.0	6.2	0.0	0.2	1.3	0.3	1.1	0.8	1.8	4.9	0.5	2.2	0.5	0.4	0.2	2.3	3.8	0.1	4.2	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.3	1.4	4.4	1.3	4.4	1.6	1.9	2.2	2.4	0.8	2.2	4.2	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 160.2"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 149.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 11.5;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.2	0.0	0.4	0.1	0.3	0.0	0.2	0.5	0.7	1.1	0.2	0.1	0.5	0.1	0.6	0.1	0.5	0.0	0.2	0.3	0.7	0.4	160.2	0.1	0.0	0.3	0.5	0.4	0.1	0.2	0.4	0.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.1	1.5	0.6	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.7	0.3	0.7	0.3	0.5	0.3	0.2	0.6	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.3	0.5	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	8.0	0.3	0.2	0.0	0.4	0.0	0.2	0.0	0.3	2.2	149.3	0.1	0.0	0.5	0.4	0.0	2.8	0.7	0.2	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.5	0.1	3.2	4.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0
FAHD2A	CGI-105	ENSG00000115042	"Fumarylacetoacetate hydrolase domain containing 2A"	Q96GK7	2	95402708-95416616	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 101.7;Hepatocytes: 99.3;Proximal enterocytes: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042145, HPA044987, CAB045971, CAB045972"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB045971: AB_11126570, CAB045972: AB_11140511, HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.52e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.77e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.55e-2)"	21.0	22.1	22.6	8.7	24.2	14.7	21.8	25.5	29.7	18.4	18.8	18.3	32.4	19.0	5.3	13.3	17.8	10.9	39.3	23.5	22.4	28.6	114.8	13.9	10.9	22.3	22.4	22.6	30.0	18.1	12.3	10.8	22.7	15.5	13.9	5.9	86.2	12.2	37.8	18.5	25.4	15.3	21.2	14.6	26.1	29.9	23.3	18.6	37.8	57.9	12.2	14.3	15.7	27.6	30.2	27.9	31.7	20.4	34.4	31.1	22.4	28.2	47.5	32.5	51.6	17.6	12.9	18.5	12.1	29.1	41.0	16.2	22.8	25.7	32.3	16.0	27.9	14.9	13.2	29.1	44.3	22.8	8.2	29.9	28.6	30.0	37.9	51.6	43.2	35.6	21.6	41.1	41.6	36.6	40.6	31.1	10.2	17.6	27.2	29.9	20.0	52.0	36.3	12.1	18.9	9.3	16.8	27.0	33.2	39.3	16.9	9.0	20.4	41.2	28.3	17.6	19.6	44.0	20.3	18.8	28.0	20.5	20.9	3.3	15.7	8.1	18.2	17.8	20.7	15.5	16.7	17.6	23.3	10.4	16.8	14.2	1.0	12.3	9.0	27.3	19.6	14.4	22.6	24.2	25.5	29.7	23.5	22.4	22.3	22.4	22.7	21.2	23.3	27.6	14.6	9.6	12.5	10.7	13.8	9.8	13.8	14.6	21.1	17.6	26.6	26.4	36.8	28.6	16.8	29.5	10.4	30.3	16.6	14.4	70.5	29.5	101.7	11.2	10.5	13.9	4.9	14.5	15.2	23.1	14.7	21.4	21.9	7.7	4.5	32.7	16.4	99.3	26.0	16.8	13.2	17.3	10.2	12.0	8.3	87.1	37.0	11.0	17.8	2.8	19.8	22.2	13.4	3.5	10.8	18.7	17.3	52.3	23.9	15.4	104.6	52.7	15.0	18.8	13.1	15.3	21.3	49.1	19.1	19.0	7.7	17.1	12.4	36.5	23.9	12.1
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1123.3"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	27.2	12.4	2.5	0.9	2.7	0.4	6.8	2.5	3.6	1.2	2.3	1.4	1.8	1.3	3.0	5.1	13.3	1.8	4.2	2.3	2.6	14.0	1123.3	18.7	4.9	5.0	2.7	0.3	4.5	4.2	4.3	0.2	3.1	1.1	0.7	0.1	5.1	0.4	4.6	4.3	2.2	1.6	4.0	0.4	3.9	0.5	2.8	1.4	2.6	3.1	9.1	1.0	0.9	2.6	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	2.5	3.6	2.3	2.6	5.0	2.7	3.1	4.0	2.8	2.6	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355158-133358025	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 61.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Approved					NA	NA		2000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	12.9	8.8	4.2	11.3	4.4	6.6	13.0	4.0	7.2	7.3	8.2	12.0	52.0	5.5	3.2	8.7	7.9	9.6	17.4	4.2	4.6	46.7	228.3	14.1	16.8	5.3	4.7	7.3	18.3	8.0	6.0	5.2	5.7	7.0	5.4	0.3	28.8	3.6	3.0	7.4	46.8	3.6	4.9	23.7	8.5	5.6	5.1	6.1	6.6	2.6	8.0	7.9	7.7	4.8	23.3	7.2	13.6	28.4	3.8	9.2	24.8	18.3	20.7	6.5	8.1	46.4	12.4	0.0	20.7	13.8	0.0	1.2	4.9	6.3	0.5	8.4	4.9	22.3	10.3	50.7	20.1	25.2	14.8	9.6	0.2	2.6	1.4	3.0	9.2	22.9	22.2	29.7	13.9	23.0	3.9	33.6	9.5	13.5	3.2	21.8	0.4	13.0	7.5	0.0	1.4	11.0	6.7	20.6	25.3	6.8	0.2	38.3	18.7	0.1	18.4	0.0	0.1	15.5	2.7	16.7	5.5	10.2	7.1	0.1	68.9	6.5	16.0	73.2	14.7	36.0	14.0	13.4	57.2	34.5	14.9	13.1	3.3	17.1	15.7	79.0	10.4	28.6	4.2	4.4	4.0	7.2	4.2	4.6	5.3	4.7	5.7	4.9	5.1	4.8	20.4	6.4	10.0	0.0	32.7	12.1	9.2	8.5	6.2	0.1	12.2	25.7	10.9	22.8	11.4	9.2	0.0	10.3	25.1	79.2	31.3	13.6	3.7	3.8	9.7	14.1	3.0	24.4	0.6	12.7	9.0	25.6	8.6	7.7	27.3	15.5	25.0	564.7	172.0	0.0	1.2	49.7	6.1	103.0	55.4	10.3	10.2	68.7	26.6	1.9	85.6	3.5	13.4	0.0	1.0	12.5	119.5	3.8	29.6	17.8	690.7	368.1	4.0	1.1	13.1	11.6	14.9	20.2	23.7	10.0	9.9	6.6	21.5	4.1	61.1	12.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.1;liver: 286.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.7	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.1	75.1	286.7	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 136.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.8	7.1	0.8	0.2	1.3	0.9	0.6	4.7	1.6	0.5	1.4	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.0	1.3	0.5	136.4	0.2	0.6	1.7	1.2	5.8	1.8	0.2	0.4	0.2	1.6	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.3	1.6	6.5	2.7	1.1	0.2	0.1	0.1	0.3	0.3	0.4	1.4	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.8	1.3	4.7	1.6	1.0	1.3	1.7	1.2	1.6	0.3	1.1	1.4	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149865-112215377	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 305.7;liver: 144.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Hepatocytes: 184.5;Horizontal cells: 45.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.3;Hep G2: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	305.7	33.9	14.9	4.8	17.1	3.4	67.7	12.2	14.0	3.0	6.9	6.4	4.0	4.2	75.1	2.9	3.1	6.0	12.3	12.4	13.0	4.4	144.1	4.1	4.6	12.9	16.0	5.3	5.0	4.3	2.1	3.0	12.1	3.9	4.7	5.1	17.2	5.3	8.3	3.2	6.1	4.9	11.5	2.9	4.9	5.6	15.7	3.6	12.4	8.8	4.3	4.8	2.6	10.5	9.9	7.4	9.7	12.9	250.3	9.1	12.7	9.2	10.5	6.6	5.1	17.3	5.7	6.9	5.0	6.5	6.1	12.3	15.5	7.9	12.3	5.0	8.4	6.4	7.9	71.8	7.7	11.2	3.4	43.8	13.1	11.7	23.6	49.7	5.8	9.7	8.5	6.1	7.7	5.6	9.6	8.8	8.1	5.6	10.1	9.7	25.4	5.1	4.3	6.8	4.1	12.1	12.8	6.1	14.5	8.9	6.3	4.0	4.4	7.5	4.6	9.4	14.8	6.1	7.3	14.3	8.8	9.8	5.8	0.0	0.3	0.1	0.7	0.4	0.9	0.5	0.5	0.5	0.4	1.1	0.5	0.9	0.0	0.3	0.3	0.6	0.6	0.3	14.9	17.1	12.2	14.0	12.4	13.0	12.9	16.0	12.1	11.5	15.7	10.5	9.1	9.6	27.1	90.8	5.2	0.4	0.8	1.6	4.6	5.3	8.1	8.4	18.9	20.0	4.3	5.5	10.4	5.2	4.3	1.7	1.9	2.7	0.5	5.1	10.0	5.0	1.2	12.2	8.2	3.3	2.9	5.1	3.6	4.2	2.5	12.7	6.4	184.5	3.1	45.4	9.4	3.0	0.0	9.3	1.0	0.9	5.3	1.9	1.8	10.3	1.4	6.1	3.1	10.1	10.1	3.4	2.7	12.0	6.4	1.1	3.7	3.3	4.7	9.1	6.6	4.3	6.6	4.0	3.2	5.4	0.1	1.9	3.3	8.6	5.0	0.6
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320996-77331597	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 263.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 373.2;Late spermatids: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 182.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		340000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	13.9	34.7	11.1	9.7	12.5	9.3	23.2	13.2	16.3	12.7	10.5	21.9	22.5	10.8	22.1	26.9	14.9	11.9	14.3	10.5	12.3	24.5	263.1	7.8	13.5	12.6	11.7	6.5	20.1	26.4	13.3	11.2	12.8	21.1	21.7	5.1	24.1	9.6	47.4	22.1	15.6	7.9	12.3	12.1	18.9	57.8	11.9	14.0	19.5	37.3	17.4	11.9	13.8	14.0	18.8	39.0	27.6	19.9	17.1	23.9	45.8	11.4	11.9	21.6	30.9	13.0	45.2	43.5	14.9	13.6	13.4	24.1	18.9	22.5	20.7	23.2	21.0	20.8	13.3	26.9	26.3	7.8	15.8	22.1	24.0	12.4	20.8	12.0	18.6	24.7	17.5	37.0	14.5	182.1	12.2	16.4	8.2	64.1	30.3	20.2	29.5	34.2	32.5	24.0	30.2	26.2	26.0	49.1	35.6	15.5	81.2	11.1	13.8	17.0	52.5	18.9	8.6	28.2	32.7	35.2	41.9	11.3	20.8	13.4	15.5	9.9	2.6	22.2	2.4	8.2	4.6	3.7	20.7	10.4	3.9	3.1	1.6	5.1	20.1	15.0	7.9	7.4	11.1	12.5	13.2	16.3	10.5	12.3	12.6	11.7	12.8	12.3	11.9	14.0	6.1	6.4	9.6	6.5	13.5	13.4	19.8	26.2	15.9	7.3	36.1	34.2	13.0	47.1	19.0	9.2	4.2	91.4	7.5	34.9	46.9	45.0	125.8	19.4	15.6	11.1	28.8	30.3	2.9	68.0	62.5	15.0	33.1	27.0	3.8	25.7	15.4	373.2	44.6	16.8	3.3	45.7	20.3	38.1	10.9	398.1	11.8	19.0	17.8	3.7	30.4	26.4	4.1	2.0	9.2	41.8	37.4	6.0	13.2	19.8	72.9	77.8	15.0	11.9	0.0	12.3	13.2	51.3	29.4	38.0	14.1	76.2	6.7	55.8	50.3	30.3
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 173.8"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 63.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	3.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.1	2.4	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.2	173.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	63.6	0.0	0.0	7.7	0.0	6.1	1.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
H6PD	"GDH, H6PDH"	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234774-9271337	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		140000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	29.0	30.5	7.5	12.6	11.6	9.7	23.0	8.2	9.0	22.6	18.8	15.1	11.2	25.7	14.4	13.5	28.3	12.6	18.9	6.4	7.8	11.5	94.5	20.3	12.4	14.4	10.8	44.9	18.9	10.6	12.7	14.1	11.4	19.5	9.1	4.2	56.2	13.1	48.3	35.7	16.8	16.6	9.6	14.5	18.7	8.1	11.4	13.1	14.7	21.0	11.4	16.7	16.5	10.9	9.9	8.0	6.8	25.5	68.9	78.9	6.4	9.8	24.0	7.1	10.9	1.5	20.1	10.9	11.2	15.3	9.1	10.3	1.8	4.8	10.3	32.8	2.2	0.0	2.8	6.7	38.6	3.5	4.1	77.7	9.1	17.2	11.1	15.6	32.9	5.9	2.9	18.2	14.0	5.7	3.9	8.2	3.7	7.5	4.6	1.2	0.9	9.3	9.1	4.0	2.3	12.0	12.9	10.0	12.0	4.7	7.5	17.4	32.9	24.3	3.9	6.2	2.8	24.1	7.6	2.5	40.8	15.6	15.7	1.6	2.3	0.3	1.6	2.4	1.3	1.3	1.2	1.5	1.0	1.6	1.2	1.1	1.5	1.2	2.3	1.4	1.1	1.5	7.5	11.6	8.2	9.0	6.4	7.8	14.4	10.8	11.4	9.6	11.4	10.9	24.1	25.6	29.5	17.9	10.1	14.3	13.2	16.9	18.8	19.6	10.3	8.3	17.5	58.6	18.8	20.2	27.1	11.2	9.1	16.6	0.0	22.9	0.8	11.2	36.0	19.8	7.8	9.0	8.4	21.3	8.5	33.6	5.6	15.5	3.8	29.9	19.6	164.0	12.1	16.8	9.1	15.1	8.2	25.4	11.4	2.9	48.1	14.2	12.4	13.1	51.6	10.4	19.6	16.6	18.6	20.0	17.0	36.9	4.5	17.2	23.1	7.4	19.1	10.9	0.0	50.5	11.7	4.6	5.5	10.5	12.8	5.9	11.6	26.1	23.6	14.2
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2054.8"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	1.0	1.2	17.7	2.0	17.6	5.4	1.5	17.4	30.4	2.3	20.8	0.8	0.9	0.3	0.6	0.5	2.8	0.6	415.0	17.8	20.2	1.1	2054.8	3.2	4.0	48.0	24.9	3.2	88.0	0.4	5.8	2.3	25.8	2.7	0.0	4.2	1.2	1.3	1.2	1.1	0.5	1.0	21.5	1.1	1.1	0.7	18.7	0.1	0.4	0.2	4.4	1.6	0.2	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	17.7	17.6	17.4	30.4	17.8	20.2	48.0	24.9	25.8	21.5	18.7	21.0	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	583	"liver: 607.8"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 301.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049552, HPA072442"	Enhanced					NA	NA		240000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	607.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	301.4	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 968.3"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000	"Cluster 35: T-regs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	22.4	7.7	9.8	14.6	15.4	0.3	12.0	23.0	22.0	2.8	8.1	4.2	1.2	4.2	15.7	2.1	5.1	8.0	7.5	11.0	16.0	24.3	968.3	39.9	4.3	14.3	21.4	59.9	3.2	0.2	8.8	72.5	16.3	27.8	3.3	0.6	2.5	13.0	5.5	33.8	5.0	12.9	9.4	7.3	7.1	7.2	12.8	0.6	5.2	10.6	1.9	27.9	6.3	17.5	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	9.8	15.4	23.0	22.0	11.0	16.0	14.3	21.4	16.3	9.4	12.8	17.5	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322886	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 573.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"							HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	9.4	0.3	0.6	0.2	0.6	1.4	6.4	2.4	1.0	2.7	0.1	0.7	0.4	2.7	0.2	0.2	1.0	0.2	0.4	0.6	0.5	0.4	573.7	3.6	0.2	0.8	0.5	0.5	1.8	0.1	0.2	0.8	0.9	4.5	0.4	0.8	0.2	0.2	0.3	6.5	0.7	4.2	0.4	0.7	0.3	0.4	0.5	0.3	0.2	0.1	0.1	1.2	7.8	0.9	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.1	1.4	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.2	1.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.6	0.6	2.4	1.0	0.6	0.5	0.8	0.5	0.9	0.4	0.5	0.9	100.0	3.2	6.4	1.6	0.0	2.5	22.6	0.3	0.0	0.2	0.2	0.3	0.3	4.3	42.9	1.8	0.0	0.1	0.4	1.0	0.0	0.1	2.7	0.4	0.5	2.4	1.8	5.3	3.7	0.4	0.3	0.8	0.0	0.1	0.0	0.2	1.8	131.3	0.2	0.0	3.0	0.5	0.0	2.4	0.4	2.7	0.0	0.7	0.0	0.0	0.3	0.3	0.0	1.5	2.8	0.1	1.4	0.4	0.1	4.7	0.2	0.5	34.0	0.1	0.0	0.7	0.4	0.0	0.9	0.2	0.4	0.0	0.7	0.2	0.7	57.0
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1804.3"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	8.5	2.5	13.1	6.9	16.2	0.5	0.7	13.4	18.9	28.0	9.4	24.7	3.2	20.9	1.6	9.9	6.5	9.1	0.8	12.3	12.6	2.5	1804.3	63.2	0.8	12.0	14.6	6.0	0.6	0.5	0.6	5.4	11.5	51.2	7.6	0.8	0.4	69.2	0.4	1.2	4.8	13.1	12.4	47.5	5.7	23.3	13.7	0.9	31.4	0.5	0.9	36.7	14.6	12.8	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	13.1	16.2	13.4	18.9	12.3	12.6	12.0	14.6	11.5	12.4	13.7	12.8	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 116.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.3	0.2	0.5	0.3	0.9	0.4	0.4	1.4	0.8	0.5	0.9	0.6	0.3	0.2	0.1	0.1	0.7	1.6	0.2	0.3	0.1	1.0	116.7	0.8	0.0	0.7	0.4	0.7	2.5	0.0	0.7	0.0	0.8	0.5	0.1	0.2	0.8	0.1	0.5	0.9	0.6	0.0	0.4	0.3	11.0	1.9	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.4	0.8	0.3	0.1	0.7	0.4	0.8	0.4	0.4	1.8	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1198.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000		"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	2.6	0.1	0.2	0.0	0.2	0.0	2.4	0.2	0.3	0.3	0.1	0.0	0.3	79.6	0.1	0.0	4.1	0.3	0.5	0.2	0.3	1.6	1198.4	0.1	0.1	0.8	0.3	46.3	0.5	0.0	0.5	204.5	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.3	1.1	0.3	0.0	0.0	0.0	0.2	0.2	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.8	0.3	0.9	0.2	0.3	0.2	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 225.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 23.8;neutrophil: 95.0"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 95.0"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		350000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	6.2	2.9	4.0	11.4	1.1	20.3	4.3	0.0	8.7	4.4	0.5	2.2	1.8	4.0	2.6	13.1	5.4	12.1	3.9	4.6	3.1	3.3	225.8	8.2	2.7	2.4	3.7	3.0	3.9	1.5	1.2	37.0	3.3	3.9	2.2	2.4	5.2	3.4	1.3	11.9	2.2	6.4	1.5	5.4	4.5	1.3	5.5	4.6	4.0	2.1	4.8	9.4	5.5	3.3	13.3	3.0	5.5	0.8	9.5	7.7	10.0	5.8	11.9	13.4	13.2	5.8	29.3	2.2	59.2	16.4	31.1	34.1	3.0	57.6	18.7	2.5	3.6	2.9	5.3	14.5	19.6	20.2	9.5	10.3	23.1	19.7	59.2	27.8	6.0	5.9	0.4	0.2	6.4	6.5	1.7	9.4	8.5	6.0	6.0	9.5	8.2	4.8	5.3	14.8	1.0	0.0	26.3	15.0	247.1	5.2	9.6	14.6	7.9	10.3	10.4	32.1	26.6	5.0	0.2	0.5	17.2	18.0	60.9	11.7	3.8	23.8	1.8	4.3	3.3	2.1	2.1	2.3	3.8	2.1	2.0	1.3	95.0	0.3	6.3	0.6	2.1	1.4	4.0	1.1	0.0	8.7	4.6	3.1	2.4	3.7	3.3	1.5	5.5	3.3	3.5	0.0	14.7	6.5	6.8	44.7	16.5	45.8	68.9	6.5	2.5	4.7	5.5	40.0	22.8	3.7	8.4	8.5	3.6	1.8	0.0	7.7	4.4	8.6	3.8	8.0	5.4	4.4	44.3	7.5	109.2	7.3	7.1	12.3	7.6	0.7	7.5	295.8	7.8	0.0	63.3	1.4	4.1	33.7	17.7	0.6	4.4	28.8	8.8	53.4	5.0	1.0	6.2	298.6	1.5	19.7	0.8	2.6	5.3	11.5	0.7	1.1	8.7	0.6	0.0	18.0	5.1	0.1	0.6	30.9	37.2	24.2	5.2	1.4	1.1	14.3
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"liver: 148.4"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Region enhanced"	"Detected in some"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	148.4	0.1	0.1	0.9	0.0	0.0	0.9	0.1	1.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.3	0.1	0.1	0.9	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"pancreas: 9.1"	"Cell type enriched"	"Detected in single"	11	"Hepatocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 2: Hepatocytes - Metabolism"			"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDM8	"FLJ13798, JMJD5"	ENSG00000155666	"Lysine demethylase 8"	Q8N371	16	27203508-27221768	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 80.3"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 56.4;Proximal enterocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026545	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA026545: AB_1852015"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.92e-3)"	2.1	3.5	4.0	3.1	4.0	1.3	2.2	5.3	4.2	2.6	3.2	2.7	13.3	3.0	1.8	2.0	2.5	2.2	2.4	4.1	4.0	3.0	80.3	2.2	3.4	3.7	3.5	3.0	5.1	2.4	4.0	1.5	3.9	3.6	1.7	2.3	2.3	2.1	4.6	1.7	12.5	1.6	3.6	4.6	2.6	2.7	3.8	3.5	3.1	3.0	2.6	2.7	2.3	4.1	1.4	3.0	5.0	2.7	1.1	1.5	2.7	1.7	1.9	3.8	3.3	2.6	2.4	7.6	2.9	2.5	1.9	1.6	3.0	2.7	2.2	9.2	4.4	4.9	3.3	6.2	2.7	3.6	5.5	1.9	2.1	2.4	1.7	2.2	3.1	3.5	6.1	4.8	2.4	2.3	3.4	6.4	8.5	1.1	1.8	5.2	3.1	6.9	1.4	1.6	4.8	2.9	0.7	2.5	1.9	1.7	2.7	4.8	3.4	4.5	2.2	1.7	1.8	2.9	3.1	6.3	1.9	3.3	0.4	0.2	2.1	0.8	2.5	1.9	2.1	1.9	3.6	3.5	1.9	4.3	3.4	4.9	0.1	1.3	1.9	4.0	2.3	2.3	4.0	4.0	5.3	4.2	4.1	4.0	3.7	3.5	3.9	3.6	3.8	4.1	0.7	0.0	1.7	3.3	2.4	0.3	0.2	0.7	3.4	1.9	0.7	0.6	1.5	1.5	1.6	0.0	2.1	2.0	2.4	1.0	3.9	1.3	0.6	0.5	1.2	1.6	5.4	0.8	2.4	0.7	0.7	1.0	3.1	0.4	0.0	1.5	1.1	56.4	2.0	0.0	2.5	1.6	2.0	1.9	1.2	0.9	0.3	1.3	0.0	1.9	1.4	1.4	1.0	1.5	3.2	0.7	0.5	1.2	3.0	0.5	25.4	1.4	5.9	2.5	0.0	0.9	1.4	1.1	2.5	0.6	0.0	1.4	2.0	1.6	1.2	0.2
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805384	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.5;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.7;Hepatocytes: 565.5;Proximal tubular cells: 194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048213, HPA075670"	Enhanced		Supported	"Nuclear speckles"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear speckles"		"HPA048213: AB_2680316, HPA075670: "	"unprognostic (3.71e-2)"	"prognostic favorable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	9.2	7.0	9.5	19.7	9.9	88.5	13.4	8.1	10.4	10.5	6.9	22.6	16.6	8.2	8.6	22.3	12.3	6.4	10.8	9.5	8.9	11.2	8.3	8.5	34.1	8.4	8.3	8.2	7.3	33.8	9.2	15.7	8.3	24.9	20.6	8.9	10.5	12.0	8.4	32.8	16.9	8.0	8.9	18.6	11.8	28.3	9.4	73.0	26.0	11.0	34.7	10.1	13.3	9.3	89.3	103.9	120.6	87.6	8.0	11.9	104.8	65.8	52.1	123.1	113.9	97.9	103.3	130.6	60.4	34.4	61.2	90.0	118.9	67.5	57.4	84.8	100.4	72.4	115.1	119.0	2.7	79.1	76.0	6.7	17.7	68.5	51.3	17.1	67.2	144.7	109.4	104.1	65.5	186.5	173.1	196.1	101.8	65.7	59.6	237.9	110.6	122.4	44.9	45.0	99.8	65.4	48.5	94.7	33.1	39.4	84.8	105.2	29.8	63.8	66.6	57.7	72.6	96.6	105.3	141.4	41.9	129.0	83.3	58.7	14.1	39.5	49.7	21.1	37.3	30.4	50.0	53.1	14.7	27.3	40.0	38.4	6.2	31.5	18.3	9.6	56.5	40.5	9.5	9.9	8.1	10.4	9.5	8.9	8.4	8.3	8.3	8.9	9.4	9.3	13.9	32.1	115.4	5.5	23.0	30.8	25.8	56.7	52.9	27.5	56.5	56.4	288.7	57.2	38.5	69.9	25.0	81.7	20.1	44.2	62.6	16.6	9.9	29.5	18.9	29.2	41.4	85.2	4.8	50.1	85.4	50.1	25.0	31.1	43.6	29.5	49.2	565.5	46.3	6.7	6.1	39.5	34.6	47.7	40.4	8.5	15.5	36.7	35.6	4.7	38.6	69.8	29.9	4.0	5.3	17.3	44.0	12.8	49.9	26.1	18.0	194.0	29.7	20.5	13.1	23.7	34.2	50.9	61.6	41.4	27.6	76.9	34.2	12.2	42.3	22.5
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 328.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.6	1.8	5.9	0.3	6.5	0.0	0.6	6.0	7.6	1.4	9.3	2.3	2.8	0.6	1.0	0.4	1.3	2.5	2.6	6.3	6.2	7.7	328.4	1.0	0.7	7.0	6.5	0.7	4.8	1.0	3.6	0.2	6.4	1.7	1.4	13.1	0.7	0.6	2.4	0.3	2.6	0.6	6.1	2.4	0.8	2.0	6.0	0.4	1.9	1.8	0.4	1.5	0.9	6.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.5	6.0	7.6	6.3	6.2	7.0	6.5	6.4	6.1	6.0	6.3	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717348-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 3195.2"	"Group enriched"	"Detected in some"	25	"Distal tubular cells: 655.4;Hepatocytes: 1816.9"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	47000000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	464.1	3195.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	48.6	0.0	33.1	0.0	0.0	0.0	1.8	655.4	0.0	0.4	0.0	0.0	1.5	0.0	40.2	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.0	1816.9	0.1	0.0	0.8	0.1	0.0	47.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.5	0.1	1.1	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.7	0.0	0.1	0.1
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132873444-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 532.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1650.6"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;Hep G2: 4.7;U-266/84: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		790000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.68e-4)"	0.9	0.9	0.9	0.3	0.8	0.5	1.0	2.3	1.2	1.3	0.4	1.7	12.3	0.8	0.2	1.3	1.2	4.5	1.2	0.8	0.8	11.9	532.0	1.1	0.5	0.8	0.7	1.2	1.9	0.7	1.1	0.2	1.0	2.4	1.6	1.0	1.3	0.2	1.4	1.4	23.4	0.1	0.6	2.2	2.0	1.1	0.8	0.3	1.9	0.5	0.5	7.8	1.6	1.8	0.1	0.7	0.4	1.5	0.6	0.4	0.4	0.1	0.1	0.4	0.6	3.4	0.5	0.2	0.1	0.1	0.4	0.7	1.4	0.6	0.0	1.2	1.0	0.3	1.2	4.7	0.1	0.5	0.2	0.1	0.5	0.0	0.1	0.3	0.1	1.1	0.5	0.4	0.0	0.3	0.8	0.6	1.1	1.1	0.5	0.0	0.2	1.1	0.0	0.2	0.5	0.3	0.3	0.7	0.5	0.4	0.8	0.4	0.0	0.2	0.3	0.6	0.1	1.1	3.8	1.1	0.0	0.7	0.2	1.3	0.7	0.3	0.6	0.4	0.8	1.0	0.6	0.7	0.6	0.8	1.0	0.8	1.7	1.0	0.3	0.8	1.1	0.3	0.9	0.8	2.3	1.2	0.8	0.8	0.8	0.7	1.0	0.6	0.8	1.8	2.5	0.0	2.6	1.3	7.9	10.1	10.8	4.1	2.8	17.1	4.9	2.8	1.9	64.3	2.6	0.0	33.3	3.3	7.6	39.2	9.8	2.9	6.2	4.8	3.8	5.2	4.8	9.3	1.1	9.8	7.9	5.8	1.5	10.3	7.0	6.7	14.3	1650.6	1.4	13.5	1.4	12.1	0.0	17.3	14.1	0.5	1.5	4.2	5.4	1.0	2.2	5.2	13.4	2.0	1.8	2.9	30.9	1.9	3.1	14.0	279.9	51.8	1.7	25.2	0.0	13.5	4.8	7.0	2.9	1.4	7.7	7.3	6.2	4.1	8.0	10.2
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 171.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000	"Cluster 10: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.4	0.1	0.5	0.3	0.5	0.2	1.5	0.8	0.9	0.4	0.0	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.5	0.6	0.3	6.0	171.0	0.3	0.7	0.8	0.7	0.8	2.5	0.0	1.5	0.4	1.0	0.1	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.6	0.8	0.5	0.1	0.4	2.1	1.2	0.3	0.2	1.6	0.3	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.5	0.5	0.8	0.9	0.6	0.3	0.8	0.7	1.0	0.6	0.4	1.2	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
LRRC3	"C21orf102, C21orf30, DKFZP434C128, LRRC3DN"	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455510-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.7;U-2 OS: 6.3"	"Low region specificity"	"Detected in all"							HPA017975	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	1.9	1.4	0.8	0.7	0.5	0.6	1.5	0.2	0.7	1.4	0.3	6.6	1.7	1.3	0.4	1.1	1.5	2.2	1.9	0.6	2.0	0.7	15.5	1.6	0.5	0.6	0.9	3.4	0.7	0.3	1.3	0.9	0.6	0.8	0.8	0.3	1.0	0.6	0.4	1.8	1.6	1.5	0.2	1.1	3.8	1.7	1.2	0.5	0.6	1.0	0.3	2.0	1.3	0.6	0.5	0.4	3.5	2.9	0.0	0.0	8.7	1.5	0.0	0.1	0.0	1.3	1.2	0.0	2.6	0.7	1.9	0.1	1.7	0.0	0.0	0.2	3.8	0.0	0.4	4.0	0.6	0.0	2.3	1.1	1.4	0.0	0.0	0.0	1.4	0.6	0.3	4.5	0.0	1.3	0.5	0.2	0.9	4.5	1.4	1.9	0.0	1.5	0.1	0.1	2.8	3.2	1.3	0.3	0.6	1.9	0.8	1.9	2.8	0.0	6.3	0.0	0.0	2.5	5.2	0.0	0.0	1.6	0.5	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.7	0.6	2.0	0.6	0.9	0.6	0.2	1.2	0.6	2.6	0.0	1.5	0.0	0.8	0.6	1.1	0.0	3.4	1.1	0.6	0.9	2.0	1.5	0.0	1.8	0.0	0.2	0.3	1.6	0.0	0.3	0.3	0.2	0.4	0.6	4.2	2.7	0.0	0.4	6.6	2.5	1.5	0.9	1.3	2.4	1.1	30.7	2.5	0.0	0.1	1.8	0.0	2.5	0.5	1.5	0.6	1.1	0.0	0.0	3.2	1.4	1.0	0.0	0.1	1.7	0.3	0.7	0.2	1.3	1.8	0.0	0.0	0.0	0.0	0.8	1.4	0.9	2.0	0.6	0.6	0.3	0.8	0.3	1.7	0.7
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1346.5"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.4	0.1	0.8	0.0	0.4	0.1	0.5	0.2	0.9	0.2	0.2	0.1	57.5	0.1	1.2	0.0	0.2	0.2	0.2	0.9	1346.5	0.4	0.1	0.6	0.8	6.3	43.8	0.1	0.8	0.1	0.4	0.0	0.0	0.0	0.3	1.9	0.0	4.2	0.0	0.2	0.8	0.5	0.2	3.7	0.2	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.5	0.2	0.2	0.6	0.8	0.4	0.8	0.2	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2810	"liver: 280.9"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467190-129770983	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 465.7;Proximal tubular cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	21.5	17.0	14.7	10.3	15.1	12.7	20.4	14.8	18.6	13.9	16.6	14.7	16.9	13.3	8.1	15.9	23.7	19.6	18.5	14.1	14.5	23.5	89.3	11.7	19.4	15.9	15.4	16.9	26.5	12.3	9.5	6.8	16.0	15.0	5.0	3.9	22.7	7.8	25.5	17.1	15.3	8.0	14.7	14.3	18.2	15.2	15.0	23.2	16.3	16.0	11.1	18.4	13.8	15.2	0.0	7.0	7.1	35.2	14.9	30.9	27.1	15.6	17.0	10.9	10.7	44.0	45.6	33.0	24.6	20.2	0.0	20.8	4.5	16.4	4.6	0.0	2.7	6.6	16.2	28.6	22.7	0.7	17.8	19.7	0.0	6.6	0.0	0.0	0.1	53.5	0.1	22.0	14.0	60.0	26.1	34.0	1.6	29.9	27.8	29.3	0.1	12.7	20.7	16.0	7.2	18.0	18.3	7.7	0.0	5.5	29.8	25.3	0.0	14.6	7.1	0.1	0.0	0.0	0.0	17.1	0.0	10.8	0.0	9.6	37.2	17.1	43.9	39.2	43.6	49.7	40.4	42.0	39.0	48.2	39.6	42.8	4.6	49.5	37.2	43.7	54.0	42.1	14.7	15.1	14.8	18.6	14.1	14.5	15.9	15.4	16.0	14.7	15.0	15.2	106.0	12.8	19.0	32.0	59.2	51.2	80.6	91.5	49.5	17.4	69.0	112.9	49.3	94.4	48.7	103.0	8.4	51.3	51.1	55.6	127.2	50.0	107.6	138.0	29.6	70.4	54.5	48.2	28.5	58.7	67.0	59.2	31.1	34.1	64.7	93.9	108.1	465.7	89.7	15.2	16.9	73.1	50.8	75.0	48.7	140.6	67.4	44.6	65.8	62.8	56.4	37.2	78.2	23.1	30.7	82.4	57.9	55.3	37.0	47.1	108.4	340.3	102.5	45.6	46.0	48.6	70.6	45.3	81.4	46.9	42.6	26.8	52.5	87.4	63.8	75.2
MKKS	BBS6	ENSG00000125863	"McKusick-Kaufman syndrome"	Q9NPJ1	20	10401009-10434222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Chaperone	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041071, HPA044233"	Enhanced		Supported	Centrosome		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Centrosome		"HPA041071: AB_10960408, HPA044233: AB_10962986"	"unprognostic (9.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.84e-5)"	"unprognostic (5.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.79e-9)"	"unprognostic (3.69e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.01e-1)"	12.0	13.3	15.3	6.7	16.6	1.9	12.3	17.9	19.2	14.3	19.6	18.9	17.3	12.6	13.7	12.7	13.1	12.7	20.6	17.0	17.2	28.8	26.0	9.9	8.4	16.4	15.2	13.8	12.4	25.5	14.8	9.6	17.0	15.0	19.4	22.8	13.0	15.4	25.4	9.3	14.5	14.3	15.4	11.8	13.9	16.2	16.3	12.2	17.6	40.6	10.7	14.4	13.3	16.0	18.9	23.3	21.7	32.9	23.3	20.9	6.7	12.7	14.4	16.6	13.3	7.7	9.6	16.2	5.3	12.4	30.0	25.0	27.6	25.1	20.6	2.9	10.4	37.1	5.8	20.9	15.8	23.4	7.5	18.5	47.5	16.0	31.7	28.0	13.5	14.8	18.8	11.7	19.7	7.1	22.3	14.2	15.6	60.8	16.4	13.2	21.5	14.5	25.7	8.6	33.0	20.9	11.9	61.3	29.7	14.5	16.8	15.5	6.3	14.6	12.4	17.8	23.3	8.6	36.3	6.9	12.1	24.3	15.3	19.5	16.0	13.4	11.7	14.2	13.8	11.3	13.0	9.9	16.8	7.8	15.1	14.1	7.9	11.9	16.9	10.8	11.0	16.4	15.3	16.6	17.9	19.2	17.0	17.2	16.4	15.2	17.0	15.4	16.3	16.0	15.0	3.2	17.9	20.5	29.8	33.9	56.5	143.1	39.9	39.1	11.5	13.7	225.7	118.7	67.0	9.2	12.5	101.6	50.3	116.4	68.4	27.0	95.4	14.7	11.5	41.2	71.2	43.5	30.2	19.8	83.4	40.1	37.8	11.5	22.8	9.1	57.5	182.4	127.1	69.0	36.1	90.0	89.5	62.5	67.5	41.7	62.4	34.5	49.8	11.2	51.1	70.7	55.6	25.6	24.7	17.6	92.9	63.9	31.5	87.4	99.6	47.4	54.7	40.1	52.6	43.9	51.5	229.1	73.6	86.4	42.8	96.9	23.5	13.0	100.7	75.5
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187497-36272157	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 10.3;liver: 16.0"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 18.8;Hepatocytes: 39.4;Proximal enterocytes: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 40.7;hTERT-HME1: 49.7;SiHa: 54.9;SK-MEL-30: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	2.0	10.3	0.3	0.9	0.3	0.3	2.5	0.5	0.5	0.9	0.5	1.6	6.1	0.8	1.9	3.8	1.7	1.4	0.3	0.4	0.4	1.2	16.0	1.6	0.2	1.2	0.3	6.4	0.8	2.3	2.0	1.0	1.3	1.3	1.6	0.7	1.8	3.3	0.6	2.0	6.4	0.6	0.2	0.3	1.6	0.9	0.6	0.1	1.2	0.4	1.2	2.7	0.7	0.3	14.3	4.8	0.2	0.1	4.3	5.5	2.9	8.2	4.6	3.9	10.0	3.1	4.4	0.1	2.5	13.4	1.0	8.6	2.9	12.9	5.4	2.4	2.3	0.2	13.5	11.8	14.6	0.1	3.8	8.7	40.7	15.2	49.7	0.5	0.6	0.1	4.9	0.1	6.2	3.6	0.0	0.1	0.8	3.4	4.1	0.0	0.1	0.0	5.5	18.5	0.1	1.2	54.9	3.3	38.8	0.9	2.5	0.2	2.7	3.0	3.7	6.7	1.4	0.1	0.1	0.1	7.8	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.5	0.4	0.4	1.2	0.3	1.3	0.2	0.6	0.3	0.9	12.8	5.0	0.3	0.9	0.6	1.4	3.7	1.8	0.3	4.5	1.9	1.0	4.3	6.4	0.0	2.1	0.5	0.2	2.2	0.0	3.1	7.2	5.9	3.4	0.8	3.0	0.0	0.9	12.4	4.3	2.4	1.5	18.8	0.0	2.0	0.4	39.4	0.6	0.0	1.1	3.1	6.1	0.6	2.6	3.2	1.8	1.0	3.6	4.7	11.9	6.6	0.0	1.0	0.3	4.6	2.3	9.1	0.9	2.3	22.4	0.2	4.5	0.5	0.0	6.5	1.2	0.1	0.3	5.1	1.3	2.3	0.5	2.7	4.5	2.2
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 255.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	42.9	7.3	9.2	15.4	7.8	0.6	27.4	3.5	11.4	13.3	5.8	23.7	13.2	16.2	16.6	15.9	9.2	26.7	19.1	7.1	5.3	25.6	255.5	74.9	11.3	4.2	8.9	14.0	49.3	34.6	5.8	48.4	6.0	15.1	22.0	21.5	12.8	17.7	9.2	15.3	13.4	20.1	3.9	8.2	12.2	9.6	13.2	17.4	19.3	13.6	10.5	25.4	14.3	6.7	102.5	51.7	82.6	24.9	22.4	95.0	74.6	190.8	93.9	129.0	127.4	63.9	8.9	0.1	31.0	220.5	52.1	221.0	27.4	164.3	161.1	0.3	23.9	0.2	22.6	82.3	52.1	2.2	0.6	38.6	111.1	135.0	360.0	47.6	23.8	42.4	0.2	0.4	120.7	43.5	39.7	12.4	53.9	6.7	81.2	50.5	52.6	7.7	51.0	42.8	41.8	109.0	64.5	11.1	57.9	70.2	10.1	3.1	29.1	122.7	61.5	75.0	22.7	0.9	0.5	1.1	74.4	0.4	69.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	7.8	3.5	11.4	7.1	5.3	4.2	8.9	6.0	3.9	13.2	6.7	95.8	330.2	112.5	1.6	3.6	76.7	58.2	78.7	31.9	1.4	29.0	22.9	7.9	45.8	84.3	69.9	0.0	5.2	0.8	30.4	0.0	120.4	2.9	13.0	20.2	60.5	58.5	10.7	22.3	44.6	26.5	40.3	18.3	18.1	3.8	129.1	5.0	414.2	4.2	0.0	38.0	24.6	34.6	10.5	10.0	3.8	5.0	2.3	26.6	70.3	1.0	72.2	0.0	1.0	0.8	38.1	54.1	9.1	0.4	112.2	4.5	1.2	48.2	2.7	203.8	32.6	160.1	2.4	21.0	13.9	28.1	3.4	3.3	44.9	38.0	47.1
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391282-18401218	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 33.5;liver: 128.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 14.8;Hepatocytes: 59.0;Paneth cells: 15.9;Proximal enterocytes: 36.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.0;RT4: 1.6;SCLC-21H: 2.2;SK-BR-3: 1.4"									HPA043704	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"			"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.1	0.1	0.2	1.6	0.2	0.0	1.1	0.2	0.6	0.5	0.1	15.0	33.5	0.9	0.7	0.1	0.2	0.2	0.2	0.2	0.2	1.9	128.6	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.1	0.4	13.2	0.0	0.0	0.5	0.0	0.0	25.6	1.6	0.2	1.3	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	1.0	1.6	2.2	0.0	0.0	1.4	0.0	0.1	0.3	0.2	0.5	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.0	0.0	14.8	5.9	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	59.0	0.2	0.0	0.0	7.4	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	2.6	0.0	0.0	36.0	0.8	0.3	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	4.4	0.1	0.8	6.7	0.1
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068297-78079862	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA038873: AB_10673480, HPA056195: AB_2683063"	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	202.3	278.0	118.8	84.5	126.1	126.1	143.0	128.7	150.7	103.0	125.6	143.6	218.4	125.3	68.4	142.6	120.2	108.6	240.7	129.0	145.8	151.1	286.8	100.0	109.1	121.6	117.1	96.2	168.8	186.1	133.5	74.8	124.2	88.7	66.1	59.8	275.1	83.2	487.6	121.9	194.3	63.6	136.8	96.2	130.0	103.0	126.1	73.5	207.0	254.0	62.8	97.1	100.1	136.3	287.6	342.2	183.3	118.8	168.3	105.6	227.2	335.7	190.9	252.4	179.9	910.4	311.8	166.3	583.3	155.8	210.2	293.1	136.1	190.9	99.5	318.8	386.7	183.8	337.4	727.9	270.9	409.7	164.2	147.9	177.8	195.6	75.2	156.0	172.9	158.8	365.3	278.4	137.9	478.7	254.5	722.4	212.4	670.4	415.6	224.5	352.5	570.5	196.4	420.7	261.2	229.0	235.0	499.5	182.3	158.8	391.4	328.2	241.0	256.4	314.9	611.8	297.9	251.5	541.9	400.4	146.4	236.6	251.0	374.5	337.6	354.0	150.1	293.0	138.3	230.8	172.4	163.4	363.5	212.1	144.5	159.8	102.2	225.4	243.0	290.4	202.7	410.9	118.8	126.1	128.7	150.7	129.0	145.8	121.6	117.1	124.2	136.8	126.1	136.3	256.6	166.7	194.7	0.0	106.4	95.5	166.1	443.7	40.5	145.8	346.2	414.0	240.9	243.1	288.2	391.8	66.7	408.8	166.4	206.3	305.2	395.6	311.8	413.8	129.3	183.7	167.9	106.5	0.0	431.5	392.8	165.7	43.3	241.7	153.2	158.1	184.9	856.9	346.2	90.9	0.0	317.9	429.3	174.5	110.7	84.7	215.6	129.4	245.5	0.0	246.7	310.0	175.1	0.0	0.0	456.5	329.1	201.6	102.5	239.0	461.8	454.6	300.0	131.6	236.7	154.5	222.7	384.4	162.1	67.5	114.4	387.1	109.9	226.3	373.2	215.6
NFIC	"CTF, CTF5, NF-I, NFI"	ENSG00000141905	"Nuclear factor I C"	P08651	19	3314403-3469217	"Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 293.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 168.4;U-2197: 164.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004300, CAB004674, HPA052625"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889"	"unprognostic (2.59e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (1.52e-6)"	"unprognostic (8.38e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-3)"	42.9	51.0	18.8	18.0	28.4	9.3	38.5	27.2	46.4	50.5	14.1	58.9	9.2	53.6	10.1	32.5	44.7	16.3	62.6	15.5	17.1	21.2	56.8	34.7	6.3	40.0	33.6	52.3	68.7	29.5	29.2	7.5	39.4	39.2	7.7	10.5	45.3	33.1	293.6	42.0	22.9	28.8	31.4	20.1	43.1	13.1	35.7	7.8	33.7	63.1	5.7	46.3	36.3	30.0	63.5	92.8	1.1	53.7	47.9	41.2	5.6	55.6	30.3	36.9	25.7	2.3	20.8	0.5	19.2	51.1	26.4	30.1	15.4	37.8	15.6	44.6	13.7	11.6	75.1	19.2	37.2	19.0	22.8	34.8	25.9	50.2	19.8	24.3	34.9	3.6	32.8	55.3	28.1	45.7	11.1	4.0	3.0	2.8	37.8	28.1	34.0	23.1	14.7	13.3	12.6	32.1	168.4	16.4	17.0	0.8	48.7	14.1	49.5	61.7	56.2	164.1	76.3	1.9	2.5	0.5	83.9	38.6	91.8	1.5	4.1	1.8	2.3	4.0	1.9	1.5	2.2	2.2	3.1	1.6	1.5	1.5	8.7	5.9	0.9	1.2	0.8	3.0	18.8	28.4	27.2	46.4	15.5	17.1	40.0	33.6	39.4	31.4	35.7	30.0	96.4	80.1	82.6	40.8	18.9	100.1	136.5	85.5	174.8	189.5	117.1	101.2	124.8	270.2	50.0	92.0	58.4	9.7	12.4	25.6	52.8	146.5	32.0	77.7	156.3	101.9	47.9	31.1	42.2	190.8	5.9	174.6	80.5	140.1	26.0	85.5	112.5	394.2	55.9	80.8	34.4	41.9	63.1	146.1	50.2	22.0	252.5	58.2	46.2	46.9	56.8	151.1	11.3	21.1	44.5	113.8	32.0	253.2	20.8	175.1	27.0	59.4	67.7	65.4	72.3	285.7	110.8	14.6	39.2	124.7	97.7	8.5	26.1	62.3	59.3	101.2
NMT1	NMT	ENSG00000136448	"N-myristoyltransferase 1"	P30419	17	44957992-45109016	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 344.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022949, HPA022963"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		94000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane"	"HPA022949: AB_1854534, HPA022963: AB_1854535"	"unprognostic (1.40e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (4.96e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.17e-3)"	"unprognostic (9.45e-2)"	28.3	31.8	36.2	22.3	37.7	19.5	25.8	30.3	43.4	24.7	27.9	27.8	23.6	26.4	15.7	28.8	27.7	20.3	28.3	38.8	36.4	27.3	39.5	26.5	33.6	35.4	33.7	26.3	22.2	37.8	23.3	36.6	35.0	24.5	29.2	25.7	32.1	27.6	44.6	23.9	26.4	32.9	33.9	28.4	24.5	24.9	37.2	35.2	30.7	47.6	39.5	33.0	23.5	34.9	51.5	88.8	53.7	42.3	82.9	75.0	60.6	41.4	87.6	115.9	101.0	83.9	57.0	54.0	86.2	80.4	78.4	51.5	94.5	92.3	132.9	117.9	73.3	49.0	60.7	84.4	53.7	71.0	62.6	66.4	64.1	79.1	69.2	64.1	87.1	60.9	81.8	38.1	63.1	49.2	76.2	31.7	42.4	151.5	87.8	57.5	67.2	52.2	73.6	78.8	39.2	32.9	33.0	30.2	38.0	112.8	73.1	46.0	50.1	69.9	49.5	55.8	68.1	41.4	61.0	69.9	64.5	44.5	56.4	34.9	49.4	20.0	23.8	33.3	19.9	42.3	19.9	20.1	26.2	31.0	23.7	18.8	26.5	21.1	27.6	115.5	25.7	11.8	36.2	37.7	30.3	43.4	38.8	36.4	35.4	33.7	35.0	33.9	37.2	34.9	50.1	38.5	29.5	49.3	53.8	13.9	15.4	48.8	24.5	97.8	74.1	57.1	46.5	97.2	33.6	69.9	116.7	73.7	87.5	48.7	78.2	69.4	31.1	51.5	63.1	46.4	50.9	72.0	30.3	71.2	61.9	39.6	21.9	62.3	22.8	28.1	85.3	344.4	47.6	129.5	30.7	43.0	28.5	86.5	15.9	12.2	55.0	34.6	10.6	18.7	97.9	41.5	59.8	20.1	19.3	67.9	52.0	51.1	31.0	15.3	84.1	108.1	24.0	123.5	59.2	16.1	46.3	67.6	35.5	20.5	14.1	81.8	40.1	25.4	68.6	18.6
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 93.6;Hepatocytes: 141.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 14.5;eosinophil: 13.6;gdT-cell: 11.0;MAIT T-cell: 19.8;memory CD4 T-cell: 17.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 21.8;naive CD8 T-cell: 14.5;NK-cell: 20.8;T-reg: 29.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;NK-cells: 20.8;T-cells: 29.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 102.6;TIME: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	25.9	4.4	7.3	6.1	8.7	3.7	17.5	12.2	10.0	9.8	4.0	8.8	6.6	12.7	3.5	7.0	8.3	7.0	8.7	7.0	4.9	9.4	16.8	6.3	8.9	5.0	7.6	15.4	5.6	16.5	5.5	4.4	5.1	9.0	9.2	7.0	5.2	7.7	8.3	10.1	10.9	10.5	4.3	9.4	7.9	13.4	9.1	27.0	5.9	8.5	8.0	8.6	7.9	7.3	8.8	11.3	12.7	9.3	33.7	35.9	2.3	18.8	15.3	17.0	23.0	10.9	38.7	0.4	12.7	102.6	46.6	10.6	11.4	10.7	28.3	11.7	13.9	23.4	5.4	15.2	22.4	1.7	84.0	31.9	10.8	23.8	7.2	62.2	65.8	16.3	11.2	1.5	63.7	10.9	18.3	4.4	9.3	10.0	10.5	13.6	18.5	1.8	12.6	1.8	3.9	14.4	22.8	3.7	6.3	10.5	11.7	7.3	147.1	16.7	24.4	75.0	13.7	13.0	14.3	1.0	20.7	6.3	12.4	14.5	0.5	13.6	11.0	0.7	19.8	2.2	17.5	12.9	0.5	2.5	21.8	14.5	1.9	20.8	0.8	0.5	29.5	6.5	7.3	8.7	12.2	10.0	7.0	4.9	5.0	7.6	5.1	4.3	9.1	7.3	52.5	9.6	8.8	25.1	16.0	16.6	23.4	8.3	7.4	20.6	14.7	13.1	13.5	57.2	10.9	27.6	4.2	1.3	16.9	32.8	9.8	33.9	6.6	4.7	20.5	21.7	18.0	15.1	39.6	19.5	3.0	16.3	9.2	10.3	93.6	13.2	25.4	141.9	2.8	20.2	30.1	11.4	4.1	7.9	7.1	14.5	21.8	5.8	12.4	17.8	10.1	12.9	40.2	12.5	15.3	27.1	15.9	20.7	10.0	17.9	38.4	63.2	5.3	17.2	0.0	13.4	21.0	8.1	46.8	6.8	14.8	2.6	33.9	11.0	18.1	16.7
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 388.9"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 3913.2;Skeletal myocytes: 1639.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 204.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 255.3;LHCN-M2: 144.1;RPTEC TERT1: 479.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		410000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	130.9	11.4	1.0	25.2	1.1	0.9	91.9	1.4	1.5	36.0	1.9	37.1	1.5	31.0	2.8	15.4	55.0	43.1	35.5	1.3	1.4	24.1	388.9	64.6	9.6	3.9	1.6	21.3	11.4	1.6	10.6	23.8	2.2	31.9	8.7	0.3	21.1	3.1	73.1	49.3	32.2	30.1	1.7	36.7	30.1	2.2	1.2	2.7	33.0	5.3	8.8	48.6	33.9	3.1	0.2	17.6	0.3	18.6	92.0	118.3	0.1	21.2	58.7	35.2	69.2	0.0	17.5	0.2	58.1	45.1	4.2	0.2	0.0	8.0	34.1	0.2	0.0	0.2	16.7	0.0	123.3	0.2	0.0	255.3	89.4	24.1	37.3	29.8	50.1	0.1	0.3	0.2	144.1	0.1	0.1	0.2	0.1	0.0	0.5	0.2	79.0	0.0	479.6	0.1	0.2	0.2	97.7	0.1	0.3	5.3	0.0	0.2	37.4	18.3	34.3	23.8	3.1	0.3	0.3	0.4	6.4	0.3	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	1.1	1.4	1.5	1.3	1.4	3.9	1.6	2.2	1.7	1.2	3.1	411.8	44.8	411.3	1.0	11.2	103.6	13.2	16.5	2.2	1.9	38.5	73.9	4.7	75.8	13.3	80.9	0.0	1.0	1.6	0.0	9.8	238.3	0.3	19.0	89.9	190.0	5.3	147.2	1.3	157.0	2.5	452.2	5.1	80.5	13.9	0.5	195.2	3913.2	28.4	0.0	1.6	0.0	0.0	126.8	142.1	1.6	74.3	9.2	96.0	1.9	5.7	0.0	0.0	0.0	0.2	323.1	0.0	13.2	1.5	10.8	0.0	99.2	11.9	0.2	0.0	1639.1	154.3	0.3	0.8	1.9	92.1	2.2	20.1	0.0	0.0	3.1
NR1H3	"LXR-a, LXRa, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269033	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 66.6;Hofbauer cells: 54.4;Kupffer cells: 100.9;Proximal enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 13.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 45.3;HSkMC: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.40e-4)"	60.7	19.9	11.3	19.4	11.8	3.3	51.1	11.2	14.3	25.3	10.2	24.6	48.4	13.6	17.6	7.6	20.3	19.6	18.5	10.3	11.1	23.4	83.8	24.1	46.7	11.0	12.1	15.2	16.7	6.8	7.2	25.4	11.7	19.4	12.0	2.2	14.8	11.5	9.1	11.7	41.0	7.9	10.5	53.2	16.3	21.8	13.8	11.0	20.3	6.3	13.6	22.4	17.5	11.5	3.5	13.8	6.4	6.1	41.0	45.3	31.1	3.5	17.9	5.7	8.8	17.0	43.2	6.1	6.5	2.8	2.1	9.2	7.6	6.1	3.8	5.8	6.1	8.3	18.7	26.1	17.5	2.9	1.0	61.2	3.7	8.7	5.5	9.7	5.0	9.4	10.2	2.5	4.5	14.8	5.8	17.0	7.1	18.7	4.5	8.4	8.3	4.1	5.0	31.9	6.1	2.3	12.2	7.9	10.4	6.1	19.5	8.8	1.3	4.5	6.1	9.1	2.0	11.9	18.3	7.6	8.2	3.9	2.2	7.8	2.7	2.5	1.4	13.3	1.9	1.0	1.5	1.3	4.3	0.7	1.7	1.4	1.6	5.8	4.2	0.7	3.8	1.9	11.3	11.8	11.2	14.3	10.3	11.1	11.0	12.1	11.7	10.5	13.8	11.5	27.2	0.0	11.3	8.1	3.0	3.3	8.6	4.6	2.2	2.4	12.7	12.1	6.6	15.7	4.9	5.5	2.1	11.0	1.5	24.4	11.7	5.8	31.0	2.4	15.3	12.5	1.8	7.0	9.2	8.7	13.3	14.1	17.9	2.8	13.3	7.1	24.7	66.6	54.4	1.7	10.9	14.6	2.0	100.9	3.3	49.0	9.0	24.7	3.6	1.0	5.4	4.4	2.1	3.0	5.6	4.2	10.7	6.0	2.4	4.1	69.5	26.1	2.5	0.8	19.7	7.4	16.3	32.4	16.8	3.0	2.4	6.6	2.1	5.4	19.0	6.3
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	11.7	9.3	13.8	6.2	14.7	4.7	11.0	14.8	19.7	15.5	11.1	16.8	6.6	15.4	3.1	11.3	13.8	6.0	15.8	13.5	14.2	9.8	21.9	10.7	8.4	15.4	13.9	16.1	9.9	4.8	11.5	5.6	15.6	11.2	5.6	1.8	16.0	11.5	9.7	9.3	11.1	5.3	13.6	16.7	13.2	8.7	15.2	7.6	9.6	6.8	5.9	11.8	12.5	14.2	29.8	74.2	20.8	32.2	8.5	15.9	22.8	12.1	13.2	23.1	14.6	53.0	28.8	63.0	25.2	10.7	15.1	26.2	26.1	29.0	4.0	28.9	63.3	19.5	47.7	60.9	11.5	22.4	22.3	13.2	14.9	12.3	13.2	15.4	33.4	37.0	22.2	22.6	9.0	34.9	33.9	88.3	46.2	37.3	47.3	80.8	22.0	103.5	17.2	10.7	43.9	43.5	13.2	41.0	25.4	7.6	29.6	23.5	12.9	19.9	21.5	17.5	23.1	30.3	38.0	26.9	8.8	31.7	24.9	4.2	15.0	3.4	14.4	26.0	16.2	37.5	17.3	16.7	25.7	32.8	12.8	15.4	0.7	19.1	22.5	26.3	34.0	14.4	13.8	14.7	14.8	19.7	13.5	14.2	15.4	13.9	15.6	13.6	15.2	14.2	47.2	28.9	27.5	2.9	12.9	8.7	16.4	21.6	8.0	8.8	18.9	23.4	14.1	44.3	28.3	3.7	0.0	10.5	8.1	75.6	17.6	16.3	8.1	20.4	19.5	36.5	67.4	26.7	3.0	9.1	18.3	17.6	16.3	23.3	5.7	20.5	51.0	866.4	13.4	6.7	3.6	85.3	54.9	25.5	17.6	23.8	33.8	9.3	21.4	2.8	9.7	10.7	18.6	3.0	4.9	12.1	81.6	25.2	16.0	6.4	12.8	28.8	23.5	8.1	13.1	8.1	23.6	5.4	32.0	11.7	10.1	2.7	12.2	20.6	56.8	21.0
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712822-205750182	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		13000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Nucleoli	"HPA062351: AB_2684745, HPA063843: AB_2685134"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	63.3	57.2	88.6	43.3	98.3	33.4	72.8	86.2	102.7	70.8	53.7	52.5	29.5	83.4	62.0	54.4	71.8	46.7	98.3	80.7	88.8	70.4	104.2	48.7	61.2	93.8	87.8	108.9	41.2	96.1	39.0	49.6	94.1	71.7	48.1	81.4	46.8	71.1	113.7	51.4	33.2	69.8	94.6	56.5	43.0	25.8	87.9	97.4	98.1	101.6	60.7	47.8	45.2	115.8	223.5	134.6	354.2	140.8	96.0	131.7	166.1	157.3	161.3	215.6	172.6	74.4	250.0	246.1	89.0	154.2	68.2	160.0	272.6	131.9	245.7	118.6	135.8	160.3	113.2	81.8	70.6	255.0	54.9	105.1	116.9	128.6	221.7	115.6	171.4	156.3	261.9	76.7	170.7	258.1	233.2	128.0	363.0	88.9	99.4	239.1	436.4	141.1	121.4	135.4	146.9	270.9	232.2	183.3	127.5	272.4	280.3	189.9	172.8	164.5	144.8	190.0	282.8	69.9	88.0	192.6	112.8	140.5	226.2	5.6	3.2	3.9	9.1	4.9	8.8	5.6	8.3	8.0	4.6	6.9	10.1	10.7	0.6	10.7	4.2	7.3	5.5	3.8	88.6	98.3	86.2	102.7	80.7	88.8	93.8	87.8	94.1	94.6	87.9	115.8	258.4	214.7	283.4	73.4	179.5	258.1	277.4	212.9	282.9	356.2	221.2	229.7	412.4	318.8	241.8	303.5	73.0	301.5	174.5	125.5	385.4	202.5	61.3	227.0	410.3	254.5	179.0	324.2	85.9	171.5	381.3	356.5	131.0	299.5	215.4	329.0	258.5	668.2	264.1	316.3	88.7	219.2	116.0	216.8	266.4	52.6	512.0	164.0	174.3	71.2	162.1	546.9	195.7	56.8	126.2	117.2	113.2	485.2	128.2	295.3	49.4	384.5	187.8	200.2	315.5	458.0	358.1	70.0	104.1	321.4	243.9	177.2	190.5	443.9	265.1	220.8
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8873.2"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	4.0	4.0	0.2	3.2	0.4	27.1	3.0	0.0	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.8	0.1	0.1	1.7	8873.2	5.8	1.1	0.2	0.3	0.3	2.1	0.0	0.2	0.2	0.1	23.6	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.2	7.3	21.9	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 112.4;liver: 377.8"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000		"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.1	5.0	112.4	0.7	0.0	0.4	0.5	0.4	0.3	0.2	0.3	0.1	377.8	0.9	0.1	0.3	0.3	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	87.4	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
PANK1	"MGC24596, PANK, PANK1a, PANK1b"	ENSG00000152782	"Pantothenate kinase 1"	Q8TE04	10	89579497-89645572	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 45.2;liver: 109.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 37.5;Distal tubular cells: 70.5;Hepatocytes: 149.8;Proximal tubular cells: 53.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.00e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.55e-4)"	"unprognostic (4.61e-2)"	"prognostic favorable (1.55e-10)"	"unprognostic (3.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	"unprognostic (6.64e-2)"	2.1	4.6	2.8	2.1	3.1	0.5	2.5	7.2	4.2	5.3	9.7	13.9	20.4	1.8	3.8	5.3	3.0	1.7	8.6	3.1	2.7	45.2	109.7	2.2	1.8	3.5	3.4	2.3	1.8	6.5	1.5	2.7	3.8	1.9	17.3	2.0	2.1	2.3	11.4	9.6	17.2	2.3	2.0	1.6	4.6	2.8	4.0	5.2	10.4	28.0	2.6	1.9	3.5	2.8	8.0	5.2	28.1	19.4	14.9	10.8	14.2	4.6	5.0	4.3	5.7	8.2	8.1	5.8	3.0	3.6	3.2	7.9	12.9	2.9	4.6	2.0	5.7	3.9	5.6	16.2	4.4	12.3	2.1	6.6	12.7	6.5	5.1	9.2	5.1	4.9	6.8	0.7	6.3	6.2	13.6	12.5	22.1	21.0	3.1	11.9	5.6	3.8	13.2	3.8	8.7	10.4	5.8	6.9	4.6	16.6	7.5	8.9	2.2	2.6	2.5	5.2	5.7	6.5	12.7	7.2	3.4	9.7	1.8	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	2.8	3.1	7.2	4.2	3.1	2.7	3.5	3.4	3.8	2.0	4.0	2.8	0.6	6.4	3.7	7.8	1.6	2.3	0.7	2.2	1.8	4.7	2.1	2.0	12.9	10.0	2.5	11.0	2.1	4.7	0.5	37.5	70.5	1.1	0.5	2.5	2.6	1.7	11.4	7.8	21.1	0.7	4.5	1.8	2.0	3.3	0.0	8.4	3.3	149.8	2.4	13.5	32.1	14.8	0.0	3.8	0.7	0.7	1.2	2.2	0.0	7.5	0.4	1.0	0.0	12.1	3.0	0.1	17.9	2.2	1.4	0.5	31.4	53.2	1.5	1.3	0.0	2.2	5.1	0.7	0.8	5.6	2.8	1.8	1.8	1.4	25.1	0.5
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 258.8"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	258.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72934762-72954806	"Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;kidney: 14.4;liver: 71.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 52.2;Proximal enterocytes: 70.0"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 9.1;Hep G2: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA		2300000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.2	27.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	14.4	71.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.3	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.8	52.2	0.0	0.0	0.3	2.4	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	70.0	13.4	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	6.3	0.0
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in all"	6	"liver: 234.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 95.9"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	3.6	5.5	19.9	4.5	19.9	8.5	3.6	33.4	26.5	6.9	21.3	4.9	3.9	5.9	8.2	4.0	4.3	4.7	5.9	20.0	20.3	8.5	234.9	3.3	7.9	16.7	17.4	6.7	4.1	2.2	9.5	2.3	16.0	6.6	2.7	42.5	4.8	3.2	8.8	14.2	5.3	2.4	15.0	9.5	4.0	4.3	20.0	7.2	5.6	4.4	4.3	4.9	4.9	19.6	2.7	3.7	4.6	2.6	3.6	5.2	4.5	3.2	2.3	1.7	2.6	2.9	6.9	7.3	3.3	1.3	1.3	2.4	1.2	0.5	1.8	8.2	3.1	5.8	6.6	3.1	2.5	3.5	1.5	4.0	4.2	4.7	4.8	7.9	0.8	8.0	3.0	5.9	2.2	3.9	13.3	11.5	5.9	2.4	2.4	3.1	1.7	3.9	4.5	2.9	3.6	4.0	2.9	2.5	2.7	4.6	1.3	7.6	5.0	3.3	2.3	2.3	2.0	6.7	5.1	2.9	1.9	4.7	1.9	1.9	0.3	0.4	0.7	0.1	0.6	1.2	0.7	0.5	0.1	0.8	0.9	0.5	1.0	0.4	0.3	0.6	1.1	0.1	19.9	19.9	33.4	26.5	20.0	20.3	16.7	17.4	16.0	15.0	20.0	19.6	1.3	0.0	3.4	0.7	1.0	1.1	0.3	0.4	1.2	10.3	1.1	1.0	2.6	1.5	1.5	0.0	6.2	0.2	1.5	0.7	0.0	1.1	0.8	1.0	1.0	1.6	1.2	4.0	0.9	0.2	0.2	1.6	0.5	0.9	0.0	1.0	1.8	95.9	0.2	5.0	1.1	2.5	0.0	1.3	0.4	0.3	1.2	1.1	3.6	0.0	1.6	2.7	1.0	0.0	0.8	0.3	0.3	1.9	0.9	0.5	0.7	1.8	2.3	18.2	0.0	2.5	1.0	0.7	0.5	1.5	1.3	0.0	1.4	0.9	0.9	0.3
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 956.3;breast: 463.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	956.3	11.3	12.0	3.5	14.8	0.3	463.0	7.4	10.6	1.4	5.3	9.3	0.5	0.7	0.4	1.3	1.4	6.6	10.4	10.0	10.3	2.7	40.8	0.7	1.7	6.9	11.5	2.1	6.1	0.2	1.3	0.2	7.8	2.6	3.7	0.6	20.8	0.6	9.5	16.0	13.9	1.5	6.6	1.0	5.5	13.2	10.6	2.3	5.3	17.3	0.1	7.9	3.1	8.2	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	14.8	7.4	10.6	10.0	10.3	6.9	11.5	7.8	6.6	10.6	8.2	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 616.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.4	3.8	2.1	0.5	2.0	0.0	31.2	1.7	1.9	5.3	1.4	2.0	7.9	0.9	3.6	0.5	1.3	4.4	1.0	1.8	2.1	2.7	616.7	14.2	0.1	2.3	2.2	12.4	14.3	0.2	24.9	0.8	2.9	0.9	2.8	0.1	26.3	3.9	0.3	7.4	3.1	0.2	2.1	0.3	2.3	9.0	2.1	1.6	7.1	0.3	5.9	1.4	0.9	1.9	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	1.7	1.9	1.8	2.1	2.3	2.2	2.9	2.1	2.1	1.9	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 107.5;heart muscle: 116.6;liver: 283.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 83.1;Hepatocytes: 307.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 64.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	5000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	33.6	8.7	1.7	8.1	1.3	0.3	24.7	1.6	2.7	14.9	107.5	17.3	13.5	16.4	2.0	16.6	19.4	33.7	116.6	3.2	2.2	37.7	283.1	39.2	4.7	2.1	2.4	32.6	5.6	13.5	8.5	32.0	2.2	8.4	21.6	4.6	12.3	10.3	4.9	20.5	20.6	19.2	1.6	11.2	10.5	5.0	2.3	1.5	17.0	16.9	3.7	18.5	15.1	1.7	0.4	2.7	3.0	27.1	112.3	100.1	1.6	4.6	9.4	1.0	6.6	12.7	1.4	0.0	30.0	3.0	18.8	0.0	1.4	0.9	1.8	0.1	7.3	51.4	1.4	29.8	8.7	1.5	1.2	78.2	0.4	4.0	0.6	63.0	7.2	3.7	32.8	0.1	49.2	0.0	0.1	0.0	3.1	2.7	6.5	0.3	1.2	0.0	27.7	0.0	7.6	19.8	5.0	0.0	157.0	0.6	0.0	19.9	9.4	14.8	2.8	8.2	1.7	0.0	0.0	0.0	60.4	30.4	27.8	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	3.2	1.7	1.3	1.6	2.7	3.2	2.2	2.1	2.4	2.2	1.6	2.3	1.7	55.9	64.1	33.8	17.9	1.9	14.8	3.6	2.1	4.0	0.5	1.7	14.0	44.6	14.3	7.5	1.8	10.4	0.6	0.5	7.5	3.9	9.8	3.2	2.1	30.7	47.1	15.7	16.4	28.4	4.4	0.7	83.1	2.0	1.1	30.9	5.0	65.7	307.1	12.8	1.7	19.7	11.6	0.0	31.5	20.6	6.3	28.6	14.6	19.6	27.2	1.3	22.8	0.0	10.6	4.6	5.6	19.3	36.9	0.3	4.5	1.9	42.2	56.6	8.1	13.1	32.4	28.4	0.4	0.7	11.8	33.2	1.6	2.1	10.8	12.6	2.3
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599893	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 278.5;liver: 594.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 5.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.9"	"Cell line enhanced"	"Detected in many"		"OE19: 909.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		2400000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	44.9	87.7	14.6	11.5	16.3	3.0	37.2	15.4	21.6	35.9	16.7	37.4	232.9	32.4	39.1	112.0	71.5	75.3	29.2	22.6	16.0	234.3	594.1	22.1	7.3	13.0	14.4	25.1	16.7	43.9	23.3	15.3	13.4	60.4	33.9	22.6	47.5	31.1	13.0	31.0	278.5	38.1	11.8	7.9	86.0	8.3	16.4	6.4	27.9	29.0	31.6	88.8	44.4	14.4	49.1	207.1	60.6	0.1	220.1	220.4	45.1	79.4	121.8	74.4	81.2	52.9	67.4	0.1	22.9	78.0	153.9	60.7	47.5	83.4	90.3	0.1	15.4	12.5	129.3	279.0	50.4	7.4	25.6	157.3	127.3	99.8	51.1	88.2	201.0	0.0	8.7	0.1	148.5	16.1	0.4	2.0	22.8	909.3	49.8	0.2	17.1	1.4	82.8	152.8	68.4	3.4	98.9	30.0	31.7	59.6	94.6	34.8	161.8	15.4	29.3	169.7	15.0	0.1	0.5	0.3	72.0	0.1	18.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.3	14.6	16.3	15.4	21.6	22.6	16.0	13.0	14.4	13.4	11.8	16.4	14.4	28.9	19.2	28.3	16.6	4.3	38.6	57.6	135.5	66.6	18.7	43.7	41.4	37.4	271.7	78.4	141.6	25.0	47.0	6.4	34.4	150.6	73.4	4.2	100.3	36.2	26.1	26.5	18.7	38.4	178.3	32.5	48.6	174.3	89.3	1.3	35.0	49.6	791.5	53.4	0.0	31.2	76.1	59.0	26.8	16.7	3.6	33.2	15.9	35.6	12.2	22.6	47.0	0.0	17.1	16.1	139.6	86.3	39.5	0.5	63.8	1230.1	581.3	80.3	46.4	13.1	17.4	61.8	15.2	5.3	242.9	30.5	20.5	5.8	46.8	145.9	156.5
PUS3	FKSG32	ENSG00000110060	"Pseudouridine synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: AB_2685126"	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.3	8.4	7.1	8.2	7.8	3.3	9.4	8.4	11.6	7.7	6.7	8.5	10.9	7.8	9.7	9.0	7.4	6.5	7.1	7.1	8.7	9.0	33.2	6.1	9.2	7.8	7.8	7.3	17.8	7.0	8.5	6.7	7.3	8.7	7.9	8.4	7.7	5.4	15.0	9.5	6.8	9.7	7.0	7.6	10.1	7.2	8.5	11.0	9.3	15.2	10.5	10.1	6.3	7.6	6.5	7.9	23.2	24.9	24.3	29.7	11.0	21.1	17.0	11.6	13.2	24.0	23.2	31.4	33.3	9.2	17.1	22.5	37.6	19.7	11.5	28.2	18.2	31.2	9.5	18.6	24.6	20.5	9.2	23.1	23.4	13.7	29.8	16.2	21.0	23.5	34.0	16.1	13.0	4.0	23.7	23.6	19.8	47.0	15.8	4.8	20.5	18.4	20.3	9.5	27.1	25.7	13.1	21.4	11.7	16.5	43.2	13.8	15.3	24.0	10.1	11.9	17.3	12.4	20.1	33.6	6.7	31.9	17.1	14.2	10.5	9.9	13.4	10.8	15.3	13.3	13.1	12.8	9.2	14.8	17.0	16.0	4.2	14.9	14.0	8.0	15.0	8.3	7.1	7.8	8.4	11.6	7.1	8.7	7.8	7.8	7.3	7.0	8.5	7.6	8.5	9.6	11.5	3.6	9.5	12.9	12.2	10.6	8.0	9.3	7.3	9.4	5.4	11.5	13.6	5.5	29.2	9.7	7.4	3.6	5.9	17.8	7.7	4.4	8.9	10.5	4.8	14.5	2.9	27.2	12.7	6.1	9.2	4.4	12.7	6.1	10.4	33.0	8.2	5.0	3.4	4.6	10.2	5.0	2.9	6.3	7.8	5.5	1.8	1.9	9.9	9.8	6.2	2.5	3.8	15.0	3.9	7.9	6.7	9.1	10.2	16.9	6.2	10.9	6.6	9.9	10.1	7.8	7.2	6.7	11.8	14.0	7.9	12.8	6.5	10.9
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341662	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 2400.4;liver: 1994.6;pancreas: 1482.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.4"	"Group enriched"	"Detected in many"	6	"AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	460000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	525.6	2400.4	61.0	87.4	62.1	0.4	295.6	56.2	70.2	522.4	321.7	386.8	53.2	359.2	55.9	78.7	408.5	116.5	212.7	62.0	63.3	271.9	1994.6	466.8	109.8	65.9	73.6	626.3	1482.0	627.1	104.1	59.0	63.3	262.5	78.3	33.9	56.2	114.7	18.3	60.4	185.9	103.0	64.8	149.5	180.0	26.9	64.5	9.8	85.0	34.6	63.1	265.3	380.7	66.7	0.0	0.1	132.9	0.3	0.0	0.0	2.1	11.9	25.2	4.2	17.2	1.2	8.2	1.1	15.0	2.9	1.3	0.5	0.0	0.0	0.0	2.4	0.5	0.6	23.6	213.8	172.9	2.2	0.4	36.4	0.0	0.0	0.0	2.8	0.0	0.4	0.4	0.4	4.2	0.9	2.1	2.4	411.9	1.2	0.0	0.1	17.1	0.4	2.8	1.1	0.6	1.2	2.3	0.1	0.4	1.9	0.6	0.0	0.0	0.4	1.8	0.8	0.6	1.4	0.9	1.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	61.0	62.1	56.2	70.2	62.0	63.3	65.9	73.6	63.3	64.8	64.5	66.7	47.1	67.3	32.0	9.4	7.0	35.1	80.7	16.8	15.9	7.0	26.2	39.0	75.0	381.8	45.0	82.8	2.1	10.1	1.9	172.6	103.7	19.8	3.7	39.9	128.7	27.1	97.4	32.0	0.4	659.2	4.3	469.6	8.2	16.4	12.0	207.5	84.6	2819.0	11.6	10.1	0.4	233.9	541.2	53.8	42.4	19.3	454.2	8.9	44.4	7.5	1.0	785.1	0.0	9.0	0.3	209.1	107.4	194.9	1.2	82.0	1.2	269.1	29.8	25.4	13.1	302.5	181.1	4.9	5.2	4.4	28.8	14.6	12.3	307.5	418.7	31.9
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 11920.3"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	730.7	32.4	30.2	6.2	34.4	1.1	394.2	12.4	48.1	5.8	12.4	11.2	4.8	2.3	0.9	1.1	2.1	7.5	16.7	32.2	113.0	142.8	11920.3	24.5	0.6	21.5	19.3	4.1	82.4	0.1	519.9	12.4	21.3	8.6	6.7	3.0	13.7	4.6	6.2	16.4	19.2	0.8	14.9	5.5	11.9	4.7	46.2	1.5	7.9	5.3	0.1	19.0	8.8	18.0	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	34.4	12.4	48.1	32.2	113.0	21.5	19.3	21.3	14.9	46.2	18.0	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792944-4885917	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.1;Hepatocytes: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 145.5;HEL: 375.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	37.2	13.4	5.8	9.0	7.8	44.3	21.7	6.5	7.3	9.4	8.2	7.5	4.1	8.3	9.9	10.4	10.6	6.3	6.6	5.9	8.0	12.3	245.8	13.1	15.0	8.4	7.9	17.6	64.6	8.7	7.0	13.8	8.8	7.0	7.5	3.8	6.8	7.1	14.4	21.1	8.0	7.7	8.3	9.2	10.4	13.8	8.1	9.7	8.2	8.6	12.5	12.5	10.6	10.2	23.3	27.6	10.3	16.5	15.0	10.1	27.3	10.8	12.0	19.9	16.8	13.9	13.4	45.2	7.4	9.7	22.1	14.4	48.0	32.5	22.8	145.5	24.2	375.0	33.5	28.1	21.5	34.1	28.9	22.4	18.2	19.0	28.7	11.2	19.7	32.4	38.9	28.0	12.0	30.4	27.8	57.8	35.7	27.7	11.0	34.2	13.8	24.2	24.3	25.9	29.6	24.3	13.6	20.0	15.8	20.4	18.9	39.8	13.9	11.6	13.3	16.6	34.0	11.5	35.3	48.1	21.3	20.8	8.1	16.2	1.6	4.3	5.7	2.5	7.0	8.7	6.5	7.7	4.3	11.5	8.7	9.0	0.6	12.1	1.3	7.4	5.9	3.7	5.8	7.8	6.5	7.3	5.9	8.0	8.4	7.9	8.8	8.3	8.1	10.2	10.9	6.4	6.8	18.9	14.7	25.5	21.8	11.9	25.0	5.4	9.3	8.0	10.6	11.5	7.8	3.7	0.0	39.8	8.5	3.0	25.4	12.4	74.1	8.3	8.8	12.1	3.0	68.4	14.1	11.5	16.6	11.9	8.6	5.7	14.5	16.7	16.1	183.4	17.7	5.0	15.9	6.4	6.1	11.3	6.2	39.7	23.0	7.6	3.6	36.5	9.7	9.2	5.2	18.1	34.3	10.6	3.7	37.6	14.3	18.1	3.2	13.7	14.0	7.0	13.1	19.1	10.2	18.2	18.4	18.6	21.2	35.4	8.9	12.1	8.9	16.6
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16"	O75452	12	56951431-56959374	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"liver: 793.0"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 365.1"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 4.3;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038518	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.3	0.3	0.9	0.0	0.9	0.0	0.3	0.9	1.1	1.2	0.9	0.3	0.0	0.4	0.1	1.4	0.5	0.0	0.4	0.9	0.8	0.5	793.0	0.4	0.1	0.8	0.8	0.5	0.6	0.0	0.3	0.0	0.9	5.2	0.0	0.4	0.5	2.4	0.2	2.9	0.5	0.0	0.8	2.5	0.3	1.3	0.8	0.2	0.3	0.0	1.3	0.3	1.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.9	1.1	0.9	0.8	0.8	0.8	0.9	0.8	0.8	0.9	0.1	0.0	0.0	2.0	1.9	0.0	1.2	0.3	0.0	2.2	0.2	0.0	2.0	5.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	8.5	0.1	0.1	0.6	0.0	13.5	0.2	0.4	0.0	0.3	0.0	0.1	0.0	0.3	3.6	365.1	0.2	1.7	0.2	0.0	0.0	6.3	0.3	5.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.3	5.7	0.0	0.1	0.2	1.0	0.0	0.0	0.1	1.4	0.9	0.8	0.3	0.0	0.6	0.1	0.0	0.3
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903341	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 3.4;liver: 5.8"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 4.3;Proximal tubular cells: 1.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.2;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RH-30: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052284	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	3.4	5.8	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497976-46500950	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	130	"liver: 119.5"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 89.6"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SiHa: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075932			Uncertain	Mitochondria		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favorable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.6	119.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	89.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231355-18236802	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"liver: 1943.5"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 28.8"	"Not detected"	"Not detected"							"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	7.4	0.5	0.3	0.4	0.3	0.0	6.7	0.3	0.6	15.6	0.3	0.2	0.0	0.0	0.2	0.5	0.5	1.0	0.1	0.3	0.3	0.4	1943.5	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.8	0.0	0.3	1.2	0.0	0.1	11.4	0.1	3.4	0.5	0.1	0.1	0.3	1.2	0.1	1.3	0.4	0.9	0.0	0.0	0.2	0.1	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.1	28.8	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	184.7	0.0	0.0	2.1	1.4	0.0	18.6	172.6	0.0	0.0	0.0	0.0	3.5	0.0	4.0	0.6	0.4	0.0	1.6	0.0	21.5	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	27.5	2132.8	0.1	0.0	0.0	0.0	71.2	38.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	706.8	0.0	0.0	0.0	23.6	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.5
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927276-53051698	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1116.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1240.7;Proximal enterocytes: 769.0;Proximal tubular cells: 881.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Nucleoplasm,Peroxisomes		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"	Peroxisomes	Nucleoplasm	"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favorable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favorable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	203.7	125.5	68.5	92.7	71.6	111.2	196.6	74.2	90.1	153.8	79.2	256.7	336.3	94.6	165.5	140.2	119.7	144.6	162.4	65.8	76.1	319.8	1116.8	140.6	106.0	75.4	72.3	94.5	119.2	130.9	64.7	79.0	77.9	150.9	270.5	76.6	114.0	97.3	142.0	130.6	305.7	112.9	75.6	83.9	234.4	63.4	74.7	131.9	140.9	152.8	125.5	139.2	76.9	78.9	120.6	64.8	85.5	157.9	273.6	232.6	92.7	140.0	208.9	90.1	129.2	58.7	127.5	114.7	147.6	206.6	105.3	82.5	59.6	131.0	136.5	168.2	86.4	123.4	88.8	122.1	182.0	179.9	197.5	190.2	175.0	107.1	52.9	196.2	260.0	132.6	111.5	58.2	184.7	70.1	200.7	155.2	94.6	304.4	126.0	101.9	150.9	158.3	252.2	192.2	70.9	85.3	122.0	246.3	121.6	189.6	125.9	201.4	203.8	122.4	63.4	213.2	114.9	95.9	131.0	134.2	159.0	175.7	113.8	285.6	193.7	286.0	185.9	208.8	152.1	150.8	144.9	184.6	230.5	132.6	120.8	171.4	29.4	176.8	204.2	150.9	195.2	289.5	68.5	71.6	74.2	90.1	65.8	76.1	75.4	72.3	77.9	75.6	74.7	78.9	167.0	134.6	198.4	52.2	91.1	150.4	123.8	222.2	110.4	37.5	189.8	86.0	157.4	258.7	166.2	185.8	31.3	182.7	128.3	512.7	473.5	168.1	57.4	150.4	81.6	126.8	235.1	93.4	45.0	162.4	156.5	124.3	180.4	125.3	138.4	54.0	146.7	1240.7	203.5	42.1	54.4	462.7	250.3	230.1	173.1	51.4	184.2	148.8	192.1	42.2	154.6	132.0	181.3	48.2	44.3	157.4	503.4	171.9	76.6	118.1	769.0	881.0	178.2	34.1	78.9	72.0	110.6	20.4	19.4	150.0	170.8	133.9	132.9	110.3	336.4	187.8
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396941-30425303	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 86.0;liver: 243.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 146.3;Muller glia cells: 112.6;Pancreatic endocrine cells: 115.2;Proximal enterocytes: 52.8;Rod photoreceptor cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 93.9;hTCEpi: 47.3;hTERT-RPE1: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		580000	"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	2.8	1.4	33.1	2.6	43.3	4.1	44.4	35.8	37.1	6.0	35.4	3.4	21.6	3.4	86.0	20.6	3.1	7.4	2.4	34.3	39.7	8.0	243.8	2.7	3.1	45.4	39.5	2.6	2.6	11.0	11.1	1.5	33.2	52.3	1.3	64.2	9.3	13.7	0.7	7.0	24.3	3.4	30.4	1.1	5.9	1.3	41.4	4.2	9.0	0.5	4.5	3.2	7.7	32.2	24.8	5.5	5.0	6.4	6.5	16.8	0.4	18.0	15.5	12.0	13.1	1.6	15.9	0.5	5.6	22.7	20.5	20.0	3.0	93.9	13.8	2.2	4.1	0.4	5.4	8.0	9.2	0.0	7.1	11.5	47.3	11.5	20.8	55.5	29.7	4.2	0.1	0.5	22.2	4.0	3.0	0.5	0.1	13.9	7.6	1.2	8.0	0.6	20.7	7.8	2.8	3.1	13.3	3.2	11.2	0.6	14.7	0.5	41.2	15.8	10.4	6.8	12.7	0.3	0.2	0.8	32.4	0.1	12.6	0.0	0.1	0.2	0.5	0.1	0.2	0.4	1.4	0.3	0.0	0.3	3.7	2.7	0.3	0.0	0.0	0.5	0.7	0.8	33.1	43.3	35.8	37.1	34.3	39.7	45.4	39.5	33.2	30.4	41.4	32.2	1.1	3.2	5.8	33.6	1.1	4.1	18.0	25.2	6.8	9.2	36.5	21.7	1.2	12.8	10.3	0.0	16.7	4.2	3.2	0.6	5.9	22.9	8.3	2.9	2.3	2.4	1.2	17.2	9.8	18.7	0.3	5.1	5.6	5.8	5.7	0.7	7.1	146.3	0.5	13.5	6.7	2.0	4.1	4.4	0.4	10.7	1.2	2.6	7.2	1.9	0.2	112.6	0.0	21.6	13.2	115.2	0.0	0.7	2.5	15.3	52.8	8.7	3.9	56.0	0.0	2.8	4.0	0.6	1.2	5.6	2.0	3.0	7.4	0.1	2.1	7.8
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1341	"liver: 5056.6"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.7	5056.6	0.3	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.2	1.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.3	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2622.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	971.5	144.2	27.4	90.0	27.5	10.9	733.0	27.1	36.0	629.4	53.4	358.7	52.0	616.7	163.3	162.0	793.2	533.0	547.1	26.2	34.8	337.3	2622.4	785.0	147.6	67.4	34.7	918.3	267.5	55.2	138.2	198.9	34.2	329.3	97.0	34.5	250.5	258.1	151.8	293.5	283.5	226.8	42.3	240.7	344.8	50.6	37.2	36.1	338.2	173.4	64.4	555.9	519.8	35.1	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	27.4	27.5	27.1	36.0	26.2	34.8	67.4	34.7	34.2	42.3	37.2	35.1	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 109.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.8;Hepatic stellate cells: 45.3;Hepatocytes: 56.7;Horizontal cells: 48.8;Oligodendrocyte precursor cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;HHSteC: 5.6;SCLC-21H: 12.6;SH-SY5Y: 11.4"									HPA006136	Approved		Approved	Cytosol		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	16.0	19.9	21.4	1.6	17.9	0.1	17.5	9.5	31.1	28.2	5.1	22.0	6.3	24.2	2.0	5.0	23.6	10.9	18.2	17.0	32.0	12.2	63.8	17.3	1.7	24.9	18.6	14.1	109.8	7.0	48.0	7.6	19.6	32.6	0.4	1.2	24.5	5.1	5.0	10.2	10.6	2.9	15.7	26.6	21.4	9.6	29.0	0.3	32.7	1.2	0.3	10.0	11.7	19.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.5	0.3	0.0	0.0	0.4	0.0	4.9	0.0	1.2	0.4	1.1	0.0	0.0	1.1	1.7	0.0	0.0	2.8	5.6	0.0	1.9	0.3	0.0	0.0	0.0	2.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.9	0.0	12.6	11.4	0.0	0.0	0.0	2.3	0.3	2.0	0.0	0.5	3.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	17.9	9.5	31.1	17.0	32.0	24.9	18.6	19.6	15.7	29.0	19.0	44.8	6.4	8.8	33.3	0.5	1.9	2.0	0.8	0.6	11.4	11.3	10.0	9.9	18.6	1.5	0.0	2.1	0.1	0.9	0.1	0.0	25.2	2.5	2.8	4.9	16.6	8.4	2.7	22.1	38.5	0.1	9.5	3.6	4.1	0.0	15.4	45.3	56.7	0.9	48.8	33.1	3.5	6.1	5.3	1.7	7.2	9.0	0.4	8.8	15.0	1.0	29.5	0.0	49.8	28.4	21.1	0.1	11.3	0.2	11.3	0.3	0.4	1.4	3.5	0.0	4.5	13.8	14.7	11.0	0.4	3.1	0.0	1.0	1.6	0.9	3.7
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	164	"liver: 426.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 147.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.4	0.1	0.5	0.3	0.0	2.5	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.1	426.9	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.5	2.5	1.2	0.8	0.4	0.4	0.4	0.3	0.0	0.5	0.5	0.4	0.0	0.0	1.3	0.6	0.1	0.1	0.4	0.0	0.6	0.2	0.1	0.5	5.7	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	1.1	0.1	0.6	0.7	0.0	2.7	4.2	0.0	0.1	0.6	0.5	0.6	0.0	0.1	1.4	147.2	0.1	0.0	2.7	0.0	2.0	3.8	0.0	5.4	0.0	0.3	0.0	2.8	0.0	0.2	0.0	3.0	2.4	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	0.0	3.4	0.7	0.1	0.0	0.2	0.0	0.3	1.7	0.2	0.0	0.1
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 79.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 609.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.1	0.4	0.3	0.0	0.9	0.3	0.3	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	609.6	0.4	0.2	0.1	0.1	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.5	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.5	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	160	"liver: 100.8"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 6.4;Hepatocytes: 21.0"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	100.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323339-100330421	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	355	"liver: 534.7"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 270.2"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	534.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	270.2	0.0	0.0	0.0	0.6	0.0	6.7	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.1
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 1023.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 144.4;Hepatocytes: 439.9;Late spermatids: 464.4"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	5.9	9.9	35.8	3.3	36.3	3.7	6.5	34.5	49.9	7.5	32.7	7.7	2.5	5.4	2.9	5.4	9.1	2.9	6.6	35.4	36.0	11.0	1023.6	4.0	4.4	35.3	36.7	6.8	10.6	7.1	10.8	1.6	35.2	8.0	1.7	3.0	9.9	4.5	4.8	6.6	3.9	4.4	35.4	5.2	7.2	20.7	38.2	6.2	6.6	4.3	4.6	8.2	6.2	34.9	41.2	55.0	9.6	10.2	9.0	9.3	6.1	2.3	5.3	7.5	10.3	4.4	8.7	52.9	6.5	2.8	1.4	8.4	11.0	35.3	3.2	24.8	37.0	35.8	58.3	46.7	13.5	18.9	12.2	10.9	5.9	1.2	20.5	12.9	3.9	39.4	33.5	0.0	9.1	33.4	47.2	39.8	5.8	34.4	31.9	23.4	0.2	72.6	25.0	19.3	13.1	17.8	0.1	53.5	12.1	2.7	15.8	16.3	3.1	0.0	6.8	0.0	4.7	33.5	41.0	22.7	10.9	35.0	2.0	0.1	4.0	3.8	13.5	5.3	29.6	24.3	17.5	18.0	10.8	15.8	21.3	21.7	0.5	18.1	4.0	18.2	23.3	13.9	35.8	36.3	34.5	49.9	35.4	36.0	35.3	36.7	35.2	35.4	38.2	34.9	12.5	0.0	7.3	3.3	9.8	9.1	15.5	16.0	14.2	11.8	50.1	73.2	8.3	20.0	9.9	5.5	0.0	7.3	6.9	4.6	39.2	9.6	144.4	12.4	10.1	11.3	10.1	25.0	4.3	15.4	3.3	8.9	8.6	8.0	5.1	20.2	16.8	439.9	10.5	10.1	5.3	4.7	6.1	16.7	9.6	464.4	10.8	6.7	16.0	1.9	3.4	12.0	12.3	5.0	7.4	8.0	1.2	9.4	8.9	32.2	1.8	57.6	11.5	8.5	6.6	7.4	18.4	50.9	12.7	15.5	14.1	3.4	11.3	26.7	6.1	15.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221544-113264492	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 20.9;intermediate monocyte: 26.8;myeloid DC: 16.3;neutrophil: 8.2;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.3;granulocytes: 8.2;monocytes: 31.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013810	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	11.5	23.9	5.7	11.1	5.8	11.7	12.7	6.6	6.5	20.7	26.3	16.3	45.1	7.2	13.7	12.0	6.5	9.6	7.4	6.9	6.6	28.7	107.6	17.7	6.3	7.2	6.9	4.9	19.1	15.2	5.8	13.5	11.7	21.3	17.0	7.1	66.5	12.8	3.5	18.5	37.4	10.0	6.8	7.6	19.4	6.4	7.0	5.5	10.9	5.8	12.4	14.3	6.5	6.5	22.1	23.4	18.7	41.4	42.0	29.8	68.8	38.3	58.0	26.0	30.1	33.5	18.8	17.2	15.2	33.0	32.9	53.3	35.8	21.8	29.0	15.2	19.9	14.2	18.7	37.6	102.3	26.1	20.6	36.1	48.3	33.6	54.6	17.4	24.0	19.6	32.8	30.9	24.8	23.6	17.9	13.2	30.4	84.2	26.0	18.3	49.1	17.2	23.6	27.2	17.7	23.1	37.0	73.0	101.5	26.2	37.2	22.0	22.3	19.3	11.9	39.1	23.2	18.5	40.5	23.6	31.9	24.2	23.1	3.0	20.9	2.5	2.3	26.8	3.2	1.7	1.6	2.4	16.3	1.5	1.8	1.7	8.2	4.4	31.0	2.3	1.8	7.6	5.7	5.8	6.6	6.5	6.9	6.6	7.2	6.9	11.7	6.8	7.0	6.5	8.0	35.3	33.5	7.5	6.6	15.2	10.6	27.4	10.2	12.6	21.4	14.9	7.4	21.5	50.8	5.5	33.3	16.5	6.9	40.2	9.8	18.3	0.3	16.2	15.6	11.6	9.0	25.4	16.8	27.2	24.1	16.0	15.3	14.5	5.1	11.4	11.4	97.1	43.4	6.7	17.0	18.9	42.7	39.4	19.9	0.9	6.2	40.3	12.4	20.6	21.8	12.2	4.1	16.1	12.3	22.3	11.1	7.2	16.1	28.9	61.7	24.7	30.1	11.2	6.6	8.4	15.2	24.4	30.7	15.1	15.8	22.4	5.5	15.2	19.9	22.6
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 609.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 289.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.8	1.1	0.2	0.3	0.2	0.0	1.2	0.1	0.4	0.5	0.5	5.1	0.4	2.2	0.2	1.7	0.9	0.3	0.3	0.1	0.6	4.4	609.9	0.3	0.2	0.2	0.3	0.2	6.6	0.2	0.1	2.2	0.1	1.3	1.3	0.1	0.8	0.5	10.2	2.6	0.5	5.4	0.2	1.2	0.2	0.3	0.7	1.4	0.3	2.6	0.8	2.0	0.2	0.3	0.0	0.0	0.1	0.0	17.7	2.2	3.4	2.3	5.6	2.0	1.8	1.1	4.3	0.0	3.5	7.8	0.0	1.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.2	0.7	0.5	0.0	4.2	0.1	0.1	1.4	0.1	0.0	0.0	0.2	0.0	43.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	14.6	0.0	0.0	86.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.1	0.6	0.2	0.3	0.1	0.2	0.7	0.3	0.1	0.0	0.0	2.6	0.5	0.8	0.0	2.2	3.4	0.0	0.1	0.0	1.5	11.5	0.2	1.8	0.0	2.5	0.0	1.9	0.0	0.0	0.2	0.4	0.2	1.2	0.0	5.3	0.6	0.0	0.7	1.2	0.0	0.2	0.0	1.6	3.9	289.5	0.5	0.0	2.2	0.4	2.0	6.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	1.2	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.0	0.1	2.8	0.6	0.8	0.4	2.7	1.3	0.1
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 128.6;pancreas: 233.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.9	10.7	3.6	4.7	4.2	35.7	11.1	2.7	5.0	13.1	2.7	15.7	8.7	12.6	10.3	4.4	13.5	18.2	8.6	3.6	2.8	7.3	128.6	9.9	7.4	3.8	3.2	20.3	233.2	1.8	4.4	6.3	3.5	12.8	9.4	1.3	13.8	6.2	17.1	18.8	9.2	8.7	2.7	8.5	30.4	3.4	3.4	2.1	12.7	9.1	6.6	16.2	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	4.2	2.7	5.0	3.6	2.8	3.8	3.2	3.5	2.7	3.4	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SMIM14	"C4orf34, FLJ13289"	ENSG00000163683	"Small integral membrane protein 14"	Q96QK8	4	39546336-39638902	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 553.9;Intestinal goblet cells: 408.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 269.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051299	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051299: AB_2681429"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.48e-2)"	"prognostic favorable (3.00e-6)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.92e-3)"	21.7	45.5	12.6	22.4	15.7	4.7	33.2	15.0	14.8	36.2	14.8	41.4	17.7	19.2	38.4	20.0	27.5	19.8	10.2	13.3	17.4	22.9	118.4	22.4	38.9	15.6	15.1	23.2	24.3	25.4	17.5	8.4	16.6	35.6	36.8	12.3	40.8	19.8	6.7	14.3	21.1	14.5	16.7	27.2	46.6	14.2	15.9	15.5	27.9	9.4	45.2	19.4	14.5	19.4	12.4	20.9	9.9	9.6	64.4	71.8	17.7	16.9	21.5	7.4	10.8	6.8	44.2	269.3	15.8	19.2	11.8	4.6	2.0	3.6	6.1	7.1	2.2	0.3	8.9	12.2	22.0	1.8	2.8	27.4	13.1	7.6	4.9	26.4	11.3	11.8	2.9	8.6	12.5	38.4	2.9	4.8	4.7	54.2	14.4	11.9	0.5	3.0	15.5	10.8	7.5	9.4	19.0	25.1	6.8	3.9	25.1	4.0	37.8	17.0	3.8	22.1	2.9	28.0	6.4	1.1	27.9	3.4	6.7	53.5	52.7	28.0	20.7	46.0	22.6	103.9	14.5	18.4	55.9	107.1	11.0	16.2	37.3	40.4	49.1	100.1	9.1	44.5	12.6	15.7	15.0	14.8	13.3	17.4	15.6	15.1	16.6	16.7	15.9	19.4	55.3	57.7	124.4	29.4	228.9	49.3	76.5	83.4	42.7	80.6	150.3	96.6	17.0	65.8	143.4	104.8	35.5	38.3	74.9	242.2	84.1	86.9	238.5	115.3	65.6	45.8	106.1	25.3	34.0	144.8	49.6	108.6	85.1	73.4	45.7	19.2	57.1	553.9	43.6	92.5	52.4	408.8	126.1	79.8	85.1	31.5	113.1	62.6	46.2	36.5	108.0	109.7	36.0	29.1	85.5	226.2	132.4	124.5	19.8	199.0	75.0	117.9	225.3	48.5	59.2	56.5	58.8	66.2	25.0	95.0	59.8	104.1	28.8	65.7	118.3	124.0
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 56.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.2	56.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4373	"liver: 519.1"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 258.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		480000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"										"prognostic favorable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	519.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.3	0.3	0.6	0.0	0.7	0.0	0.1	5.1	0.0	5.0	258.7	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1072.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	235.6	0.3	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.5	0.6	59.5	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1072.1	0.0	0.2	0.2	0.3	0.1	0.1	36.9	0.0	0.1	0.2	0.1	0.9	1.0	0.1	3.1	0.1	0.3	86.6	0.0	0.0	0.4	24.4	4.2	0.2	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.7	0.4	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1272.2"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	58.9	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.4	1272.2	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.1	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules		NA	NA		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	152.9	255.7	134.2	112.1	136.7	156.5	146.4	137.9	177.2	149.1	137.7	152.0	105.3	131.3	246.2	170.6	142.3	89.0	153.9	134.8	152.7	189.9	286.7	114.4	146.2	144.7	151.8	194.1	131.7	162.1	150.7	122.9	150.4	127.7	106.2	108.8	124.4	100.0	147.1	98.1	104.6	104.7	138.3	108.7	153.0	79.3	145.4	155.0	130.2	108.1	140.7	133.1	136.9	140.9	427.1	286.2	526.4	515.1	227.5	322.7	285.1	352.9	303.2	377.9	432.6	389.5	456.0	654.1	627.0	200.5	562.2	258.0	328.1	453.9	372.7	306.6	524.8	310.9	286.4	426.5	331.7	271.8	248.1	326.4	350.4	270.0	401.0	372.1	329.6	532.2	331.9	396.4	346.7	367.4	575.7	650.3	320.5	122.1	265.0	383.6	434.5	703.6	373.7	358.0	501.1	324.3	339.3	236.6	668.0	455.3	337.2	679.0	307.2	192.2	214.2	341.5	563.3	323.0	339.3	580.9	438.0	463.3	391.1	73.3	138.4	77.5	135.4	153.6	153.5	218.6	160.9	162.4	172.5	196.0	150.8	194.9	82.2	132.7	168.3	253.7	241.6	156.8	134.2	136.7	137.9	177.2	134.8	152.7	144.7	151.8	150.4	138.3	145.4	140.9	177.5	153.8	141.9	53.2	234.6	210.9	264.5	447.5	140.0	167.4	310.9	371.0	88.5	275.9	217.0	303.5	58.4	453.9	195.5	231.4	718.1	377.4	46.5	458.4	263.1	185.2	253.5	189.1	71.2	388.5	374.1	216.1	151.4	238.8	159.0	394.1	297.0	1298.8	411.2	148.0	73.9	300.7	252.3	495.5	401.4	42.7	306.6	226.3	225.9	40.3	394.9	231.3	254.3	66.9	126.8	476.2	283.1	258.8	182.6	406.3	256.6	1037.0	360.8	133.3	236.7	214.8	223.0	236.5	119.0	261.6	226.0	563.8	203.7	505.0	303.6	303.3
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 797.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.3	1.6	0.3	16.8	0.5	0.0	0.1	0.2	1.2	0.2	0.2	1.2	3.5	0.4	0.6	0.7	0.3	1.9	0.0	0.5	0.3	0.6	797.8	3.2	3.1	0.2	1.1	0.1	0.3	0.1	4.0	0.6	0.2	0.2	1.4	0.0	0.4	0.2	0.2	0.0	5.9	2.5	0.3	1.9	1.6	0.4	0.3	0.2	0.2	0.0	2.6	7.6	0.1	0.7	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	1.2	0.5	0.3	0.2	1.1	0.2	0.3	0.3	0.7	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1803.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2394.6;Late spermatids: 2375.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017378: AB_2669604"	"prognostic unfavorable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favorable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	333.4	364.8	332.1	276.3	361.6	315.4	416.8	347.5	376.4	413.7	528.2	493.6	475.8	252.3	640.9	406.3	431.1	360.3	215.5	301.1	358.3	1144.5	1803.2	423.3	292.3	374.4	346.9	281.2	574.2	577.5	133.7	303.1	378.7	383.2	494.4	305.0	479.8	409.3	232.1	231.4	536.1	294.7	351.9	267.8	549.8	247.9	366.9	313.0	596.4	232.3	332.3	406.2	216.5	395.2	609.6	516.6	413.3	381.1	1169.3	645.1	513.6	450.2	854.0	572.0	519.7	837.6	1703.8	380.3	746.9	882.6	598.6	648.1	363.7	659.4	619.2	551.7	390.3	606.2	367.8	414.0	707.7	701.9	959.4	657.5	1511.3	640.9	925.8	809.3	481.6	461.0	556.2	1526.5	662.5	589.5	362.1	424.2	432.1	730.6	392.2	302.8	413.0	651.0	871.5	909.9	319.0	208.7	603.5	786.1	511.2	530.7	989.4	731.6	456.8	522.6	393.9	355.8	396.9	654.2	717.8	326.8	730.9	324.3	260.8	896.4	749.8	795.5	559.9	721.8	587.8	403.6	501.1	558.5	585.5	356.6	438.9	501.8	1242.0	463.8	769.5	587.0	544.8	1813.1	332.1	361.6	347.5	376.4	301.1	358.3	374.4	346.9	378.7	351.9	366.9	395.2	428.2	477.5	455.5	80.6	314.2	261.0	535.0	836.9	222.5	245.8	526.8	337.6	221.0	571.9	766.5	544.4	114.7	406.9	366.7	995.8	131.0	927.3	1504.8	340.5	240.0	321.9	294.9	232.7	43.9	816.9	913.0	336.0	325.7	501.9	257.7	194.5	358.7	2394.6	618.9	180.0	57.3	612.6	598.1	570.6	292.8	2375.1	288.6	458.2	247.3	58.1	540.3	467.7	285.3	94.5	115.5	846.7	651.3	287.3	589.8	550.0	1585.8	809.6	874.1	154.8	170.9	191.7	361.1	458.1	214.7	272.7	235.0	891.0	315.9	372.8	552.2	654.4
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1656.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	120.9	49.5	48.5	190.8	50.1	13.5	77.8	50.7	65.8	74.5	43.0	251.8	167.7	25.9	25.7	50.4	81.5	197.3	208.5	45.4	58.0	356.5	1656.5	95.6	177.5	69.2	60.1	143.1	53.6	7.3	22.7	115.0	64.5	48.9	244.9	34.1	42.5	28.3	11.0	34.7	286.6	99.0	65.0	87.0	94.5	11.1	52.2	26.1	33.6	36.1	93.7	158.6	92.4	73.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	48.5	50.1	50.7	65.8	45.4	58.0	69.2	60.1	64.5	65.0	52.2	73.2	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	12.5	19.5	9.4	8.3	9.0	41.5	10.6	9.7	9.4	8.7	13.8	9.5	16.3	8.9	19.4	15.2	8.2	10.8	10.5	11.9	13.0	12.0	41.5	14.3	7.1	10.2	12.7	14.0	14.4	16.8	10.7	21.8	10.8	8.9	8.5	9.8	8.9	12.7	19.7	14.6	19.8	11.4	8.9	9.8	12.0	9.4	11.2	8.2	10.5	15.7	10.1	10.3	9.8	9.9	25.3	23.3	19.0	40.2	45.5	24.1	78.1	32.7	39.6	26.0	25.5	36.6	40.5	21.0	39.7	35.3	14.0	35.9	34.4	34.7	33.5	23.4	18.9	25.4	40.8	32.1	35.7	27.4	27.3	41.4	26.2	34.4	37.1	22.7	37.5	19.4	51.3	21.5	31.2	15.0	20.1	19.9	47.8	27.4	6.2	21.8	27.3	30.4	20.0	43.0	16.3	41.8	36.4	41.9	33.3	37.9	40.0	19.5	48.9	37.8	34.2	20.2	25.3	34.1	47.8	41.5	20.2	19.2	35.4	21.5	6.1	7.7	6.3	8.3	6.0	6.8	6.1	5.5	4.2	5.9	6.6	6.5	12.7	5.0	8.3	9.0	5.6	2.6	9.4	9.0	9.7	9.4	11.9	13.0	10.2	12.7	10.8	8.9	11.2	9.9	48.4	153.8	59.0	27.7	22.6	250.7	70.3	37.0	62.0	28.5	52.5	27.7	37.0	125.8	57.9	77.3	37.5	109.6	39.5	67.9	25.4	65.2	30.9	77.1	71.0	50.2	22.0	36.0	52.5	63.8	187.8	51.9	36.2	117.2	19.0	45.7	45.3	237.1	43.0	32.0	43.2	52.5	44.7	53.1	118.6	19.2	58.4	39.2	48.0	29.0	49.8	46.6	41.2	30.7	38.3	85.8	43.1	85.4	30.2	67.3	215.2	44.6	41.3	34.8	52.6	47.4	43.7	27.5	31.4	66.1	249.6	180.3	41.9	69.9	51.0	118.1
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917373-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"liver: 31.5;prostate: 80.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 45.2;Prostatic glandular cells: 16.3"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 5.5;RPTEC TERT1: 8.1;SK-MEL-30: 8.9;WM-115: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	0.0	0.2	0.2	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	31.5	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.5	0.0	0.3	80.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.6	8.1	0.0	0.5	0.3	0.0	0.1	8.9	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	1.2	2.0	0.0	0.7	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	5.5	0.1	0.0	0.7	0.2	0.0	1.1	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	2.3	1.2	0.6	0.5	0.0	2.7	0.3	1.7	0.0	0.3	0.0	4.4	0.0	0.1	0.7	45.2	0.3	0.0	0.9	0.0	0.0	0.6	0.8	3.9	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	16.3	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.3	0.6	0.0	0.1	0.0	0.5	0.0	0.0	4.1
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798153	"Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 237.3"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 506.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 168.0;ASC diff: 282.5;OE19: 188.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted to blood"	NA	NA		6200000	"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	96.5	12.1	4.2	8.3	4.5	2.1	80.4	6.5	5.8	147.1	27.8	23.5	37.1	46.4	20.6	62.8	67.7	14.9	34.8	6.5	2.7	41.5	237.3	15.0	2.4	4.4	3.1	47.0	16.8	6.4	14.8	30.3	5.0	44.0	14.4	4.1	33.9	24.6	9.5	60.0	32.3	41.1	1.9	6.9	28.2	9.1	3.9	4.7	37.6	5.7	5.6	41.6	99.6	4.4	3.7	168.0	19.1	18.4	282.5	36.1	34.6	5.9	32.2	12.6	12.0	22.2	48.0	0.3	32.7	21.1	53.7	68.6	10.9	42.7	3.9	35.7	5.9	8.3	43.5	63.1	53.6	3.0	11.9	37.3	46.0	22.5	18.2	24.0	15.7	6.4	19.9	1.4	11.7	81.9	0.5	6.5	24.5	188.9	7.4	5.9	18.3	28.7	29.7	29.7	16.8	28.5	32.7	25.7	15.4	15.8	34.5	2.7	4.9	35.4	28.2	86.8	14.2	1.1	0.6	1.4	16.6	8.9	6.4	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	4.2	4.5	6.5	5.8	6.5	2.7	4.4	3.1	5.0	1.9	3.9	4.4	6.2	0.0	0.5	1.0	0.5	17.3	12.1	25.8	27.9	3.5	13.6	13.2	3.2	11.5	12.1	1.8	0.0	50.0	0.1	33.2	0.0	6.7	0.2	8.1	35.6	5.8	7.8	13.5	0.5	21.7	71.8	33.0	14.8	10.6	1.3	38.7	9.7	506.3	9.9	0.0	0.1	12.4	26.4	9.1	6.4	2.0	37.3	0.8	5.4	1.9	1.6	9.2	0.0	0.0	0.0	21.3	21.2	45.1	0.1	14.6	28.6	21.9	3.0	0.6	0.0	1.0	11.3	0.4	2.0	22.3	22.6	43.8	1.6	8.6	13.8	20.1
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 171.5"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.0	1.3	0.8	0.1	0.8	0.0	11.1	0.8	0.7	0.3	0.7	0.5	5.9	0.4	18.5	0.5	0.5	0.1	1.0	0.3	0.6	8.9	171.5	0.3	0.1	1.1	0.7	0.6	1.2	0.0	1.6	0.1	0.6	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.1	0.0	0.6	0.2	0.7	0.8	0.6	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.8	0.8	0.7	0.3	0.6	1.1	0.7	0.6	0.6	0.6	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 165.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Hepatocytes: 72.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7"	"Low region specificity"	"Detected in all"													NA	NA		10000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	1.6	0.2	2.7	0.4	2.7	0.2	0.5	3.0	2.3	0.1	0.7	3.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	2.5	2.5	2.4	165.0	0.7	0.2	2.5	3.2	0.0	1.2	3.6	0.1	1.7	2.4	0.1	4.3	0.9	0.1	0.1	0.2	0.2	0.3	0.2	2.1	0.0	0.3	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.8	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	6.0	0.6	0.0	2.1	0.2	0.1	0.0	2.9	3.7	0.6	0.2	0.0	0.0	1.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	2.7	3.0	2.3	2.5	2.5	2.5	3.2	2.4	2.1	3.0	2.3	0.0	3.2	1.1	37.9	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	7.2	1.3	0.0	0.0	11.2	0.0	2.1	1.9	1.1	0.0	0.0	0.1	0.2	2.4	0.0	1.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	1.8	72.0	0.6	0.0	2.7	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	10.6	0.1	0.1	1.2	0.0	0.0	0.1	0.0	5.5	0.0	0.2	0.0	0.7	0.1	0.0	1.0	0.0	0.1	9.9	0.1	0.0	4.9	0.1
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"choroid plexus: 142023.1"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 23659.3"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Group enriched"	"Detected in all"	7	"cerebellum: 621.7;hippocampal formation: 1730.9;thalamus: 688.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1381.8"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	99000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	4.2	0.6	148.5	0.5	56.7	9.6	0.4	621.7	83.7	2.0	142023.1	6.0	14.9	1.3	0.9	2.2	0.8	51.2	2.9	1730.9	37.3	18.4	21288.1	0.8	2.4	106.5	86.0	1.1	1785.1	186.8	6.0	2.7	27.1	1.6	4.5	80.1	1.8	0.4	1.1	15.6	6.8	0.3	12.3	3.8	49.8	2.3	688.2	1.1	1.3	0.0	0.1	2.3	0.6	133.9	1.6	0.4	0.6	0.5	0.8	0.1	1.0	0.8	0.3	0.0	0.0	160.1	0.0	2.9	39.6	0.5	0.6	0.4	0.0	0.3	0.0	5.9	0.8	5.2	1.8	249.0	0.4	11.2	1.0	0.1	0.1	0.1	0.0	0.7	0.0	0.3	2.8	0.4	0.0	0.5	0.4	0.7	0.6	4.5	0.3	0.3	7.4	0.2	0.3	1.6	0.9	1.1	5.8	0.0	0.2	1.7	0.6	0.2	1.7	2.4	57.0	0.5	4.3	1.0	2.6	17.6	0.7	4.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	148.5	56.7	621.7	83.7	1730.9	37.3	106.5	86.0	27.1	12.3	688.2	133.9	0.0	0.0	0.0	0.0	15.1	0.5	0.0	0.0	0.0	144.8	0.0	0.0	1.8	779.2	0.0	5.5	162.6	0.3	0.0	1.5	5.9	3.1	6.8	0.5	0.5	14.1	356.2	192.5	0.0	2.0	3.6	0.7	13.3	0.0	0.0	0.2	192.4	23659.3	2.4	26.9	0.1	19.6	0.0	313.7	0.0	8.7	0.3	1.2	0.0	0.0	0.0	24.9	0.0	0.0	0.0	130.5	5.2	0.0	0.0	0.2	1.3	26.9	0.0	56.0	0.0	0.0	0.3	3.3	1.1	0.0	0.1	4.0	10.9	0.0	1.7	0.0
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 73.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HaCaT: 11.4"															NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"										"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718736-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 391.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.1"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"										"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	391.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 233.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	233.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646597-68670652	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 77.7;liver: 291.2"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.7;Hepatocytes: 142.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	21.6	5.1	0.0	0.0	0.0	0.1	77.7	0.0	0.0	0.0	0.0	291.2	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.1	17.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	4.4	0.9	0.1	168.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	24.2	3.0	0.2	0.0	0.2	0.0	2.7	0.1	3.6	0.1	0.1	0.0	0.0	0.0	0.0	2.9	142.8	0.0	0.0	0.1	3.3	0.0	3.2	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.1	0.6	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.9
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	107	"liver: 1273.7"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 883.5"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RH-30: 4.6"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	1.3	1273.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	11.7	883.5	0.1	0.0	0.1	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316014	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 5.1;intestine: 9.6;liver: 14.1;skin 1: 19.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.2	9.6	0.2	0.5	5.1	1.1	0.8	0.0	0.0	0.0	1.1	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	19.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	6.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 454.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 749.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 638.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (5.99e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.09e-10)"	"unprognostic (1.11e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.66e-2)"	99.4	107.6	56.0	38.4	60.4	55.2	87.0	60.3	73.5	111.0	64.9	97.0	44.2	109.9	87.2	51.8	90.8	58.9	99.1	57.4	59.3	122.7	454.9	77.4	35.8	64.4	59.5	115.1	168.0	51.3	115.7	45.6	63.8	76.3	41.1	23.0	92.4	69.8	34.4	81.1	82.3	84.7	59.9	62.2	88.1	55.6	68.5	35.0	76.3	32.2	32.6	100.6	88.0	64.8	73.6	187.7	57.2	165.4	638.0	389.6	68.2	269.0	229.3	128.9	218.5	79.0	83.3	54.9	141.6	331.6	87.2	66.2	79.4	103.5	139.5	81.9	204.8	52.5	239.9	378.2	103.1	104.1	74.1	225.0	54.2	173.4	146.6	336.8	141.0	78.2	70.3	130.6	253.6	271.1	74.4	205.9	106.8	98.0	175.9	132.7	160.3	286.8	127.7	61.8	119.5	146.9	118.7	84.2	137.8	91.2	138.3	123.9	126.8	171.1	61.5	159.6	101.9	76.1	80.2	50.7	445.8	174.5	90.8	77.0	127.5	196.2	118.1	94.7	116.8	91.7	116.7	119.4	127.6	102.6	102.9	101.4	104.0	84.2	98.2	157.4	143.1	112.8	56.0	60.4	60.3	73.5	57.4	59.3	64.4	59.5	63.8	59.9	68.5	64.8	95.1	57.7	51.0	5.9	30.6	84.6	68.0	157.0	10.8	12.3	93.3	117.3	20.9	141.5	64.3	108.5	8.4	85.7	48.1	34.3	62.6	204.2	6.1	25.8	83.7	89.5	67.1	32.4	8.8	129.4	293.6	132.8	10.7	48.8	55.3	60.3	118.9	749.9	184.1	10.1	7.5	44.2	46.8	80.1	94.3	13.9	158.1	66.9	115.6	5.6	107.4	68.8	51.5	6.6	17.6	103.8	28.2	172.3	29.5	59.5	152.9	204.6	33.4	19.3	59.2	78.4	99.8	30.6	34.2	10.7	112.0	39.5	39.7	82.4	49.0	55.2